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ABSTRACT
Mechanism of G protein Beta-Gamma Assembly Mediated by Phosducin-Like Protein 1
Chun Wan Jeffrey Lai
Department of Chemistry and Biochemistry, BYU
Doctor of Philosophy
G-protein coupled receptor signaling (GPCR) is essential for regulating a large variety of
hormonal, sensory and neuronal processes in eukaryotic cells. Because the regulation of these
physiological responses is critical, GPCR signaling pathways are carefully controlled at different
levels within the cascade. Phosducin-like protein 1 (PhLP1) can bind the G protein βγ dimer and
participate in GPCR signaling. Recent evidence has supported the concept that PhLP1 can serve
as a co-chaperone of the eukaryotic cytosolic chaperonin complex CCT/TRiC to mediate Gβγ
assembly. Although a general mechanism of PhLP1-mediated Gβγ assembly has been postulated,
many of the details about this process are still missing. Structural analysis of key complexes that
are important intermediates in the Gβγ assembly process can generate snapshots that provide
molecular details of the mechanism beyond current understanding. We have isolated two
important intermediates in the assembly process, the Gβ1-CCT and PhLP1-Gβ1-CCT complexes
assembled in vivo in insect cells, and have determined their structures by cryo-electron
microscopy (cryo-EM). Structural analysis reveals that Gβ1, representing the WD40 repeat
proteins which are a major class of CCT substrates, interacts specifically with the apical domain
of CCTβ. Gβ1 binding experiments with several chimeric CCT subunits confirm a strong
interaction of Gβ1 with CCTβ and map Gβ1 binding to α-Helix 9 and the loop between β-strands
6 and 7. These regions are part of a hydrophobic surface of the CCTβ apical domain facing the
chaperonin cavity. Docking the Gβ molecule into the two 3D reconstructions (Gβ1-CCT and
PhLP1-Gβ1-CCT) reveals that upon PhLP1 binding to Gβ1-CCT, the quasi-folded Gβ molecule
is constricted to a more native state and shifted to an angle that can lead to the release of folded
Gβ1 from CCT. Moreover, mutagenesis of the CCTβ subunit suggests that PhLP1 can interact
with the tip of the apical domain of CCTβ subunit at residue S260, which is a downstream
phosphorylation target site of RSK and S6K kinases from the Ras-MAPK and mTOR pathways.
These results reveal a novel mechanism of PhLP1-mediated Gβ folding and its release from
CCT.
The next important step in testing the PhLP1-mediated Gβγ assembly hypothesis is to
investigate the function of PhLP1 in vivo. We have prepared a rod-specific PhLP1 conditional
knockout mouse in which the physiological consequences of the loss of PhLP1 functions have
been characterized. The loss of PhLP1 has led to profound consequences on the ability of these
rods to detect light as a result of a significant reduction in the expression of transducin (Gt)
subunits. Expression of other G protein subunits as well as Gβ5-RGS9-1 complexes was also
greatly decreased, yet all of this occurs without resulting in rapid degeneration of the
photoreceptor cells. These results show for the first time the essential nature of PhLP1 for Gβγ
and Gβ5-RGS dimer assembly in vivo, confirming results from cell culture and structural studies.
Keywords: GPCR, Heterotrimeric G proteins, G protein βγ assembly, Phosducin-like protein 1
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CHAPTER 1 INTRODUCTION:
FUNCTIONAL PROPERTIES OF PHOSDUCIN-LIKE PROTEINS IN REGULATING G
PROTEIN SIGNALING AND CHAPERONE-ASSISTED PROTEIN FOLDING
Summary
G-protein coupled receptor signaling is essential for the regulation of a large variety of
physiological responses such as vision, heartbeat, taste, growth, and neuronal signals. The
malfunctioning of these signaling processes can lead to devastating diseases such as cancer, heart
disease, vision impairment, neural diseases, and hypertension [16-20]. GPCR signaling is
particularly important for vision. Therefore, much of the GPCR signaling pathway has been
elucidated from the phototransduction processes of the retina. Since the regulation of GPCRmediated responses is vitally important, GPCR signaling pathways are carefully controlled at
multi-levels within the cascade. Recent evidence has suggested that GPCR signaling can be
controlled by phosducin (Pdc) and phosducin-like protein 1 (PhLP1), which can bind the G
protein βγ dimer (Gβγ) tightly. Pdc is expressed mostly in the retina, whereas PhLP1 is
expressed widely among different tissues, suggesting a general role in regulating Gβγ signaling.
Genetic, biochemical and structural analyses have shown that PhLP1 serves as a co-chaperone
to assist protein folding activities of the cytosolic chaperonin complex (CCT). CCT is a large
protein folding complex that assists in folding β-strand rich, hydrophobic, aggregation-prone
proteins such as Gβ, which belongs to a class of WD repeat proteins that form β-propeller
structures. Biochemical studies have shown that that PhLP1 is required for Gβγ dimer assembly
by forming a ternary complex with Gβ and CCT and releasing Gβ from CCT to interact with Gγ
and form the dimer. Phosphorylation of S18-20 in the N-terminal domain of PhLP1 is critical for
the release of Gβ from the CCT complex. From these data, an outline of the mechanism of
1

PhLP1-mediated Gβγ assembly has been put forward. Further analysis has shown that the
mechanism of PhLP1-mediated Gβγ assembly is shared among all isoforms of Gβ and Gγ.
Furthermore, biochemical experiments have shown that PhLP1 can mediate Gβ5-regulator of G
protein signaling protein (RGS) assembly through a different mechanism than the Gβγ assembly.
PhLP1 has been proposed to stabilize the binding of Gβ5 to CCT, and then release from CCT to
allow RGS7 to associate with Gβ5 while still bound to the CCT complex. These studies have
contributed significantly to our understanding of G protein signaling because proper protein
folding, post-translational modification, assembly and membrane targeting of heterotrimeric G
proteins are crucially important for the proper function of GPCR signaling pathways.
Introduction
GPCR signaling pathways regulate a large variety of physiological responses such as vision,
cardiac rhythm, taste, growth, and neuronal signals [15, 21, 22]; and the malfunctioning of these
signaling processes can lead to devastating diseases such as cancer, heart disease, vision
impairment, neural diseases, and hypertension [16-20]. Owing to the fact that GPCR signaling
can mediate a large array of different physiological processes, a significant number of genes
encode for the GPCRs (~900 in humans [23]). Many different ligands such as small molecule
neurotransmitters, peptide hormones, chemokines, lipids, odorants and even photons of light can
trigger the activation of GPCR signaling and in turn initiate the signaling processes through
intracellular G proteins. Indeed, a large number of pharmaceutical therapeutics target GPCR
signaling pathway components [24]. Therefore, the mechanism of GPCR signaling has been
thoroughly elucidated in atomic detail [25] (Figure 1-1).
Upon binding of a ligand to the extracellular domain of a GPCR, conformational changes take
place in the packing of the seven transmembrane α-helices of the activated GPCR. This
2

conformational change
propagates to the
intracellular surface of the
GPCR and activates
heterotrimeric G proteins
that associate with the
receptor. This activation
process promotes the
exchange of GDP for GTP
on the G protein α subunit
(Gα) and leads to the
dissociation of Gα-GTP
from the G protein βγ

Figure 1-1. G protein-coupled receptor signaling cycle.
The G protein activation/inactivation cycle is shown here using atomic
structures of individual molecules. The detailed signaling cycle is described
in the text. Color code of individual molecules: GPCR – green, Gα – teal,
Gβ1 – blue, Gγ –red, RGS DEP/DHEX domain – pink, Gβ5 – dark blue,
RGS Gγ-like domain – dark red, RGS domain – orange. Reference PDB
numbers: GPCR-G protein complex (3SN6) [2], G protein heterotrimer
(1GOT) [9], Gα-GTP (1TND) [12], Gβ5-RGS (1PB1) [7].

subunits (Gβγ). Gα-GTP and Gβγ subunits can both mediate activities of downstream effectors
such as adenylyl cyclase, cGMP phosphodiesterase, phospholipase Cβ, phosphatidylinositol-3kinase, Rho guanine nucleotide exchange factors, and ion channels. These effectors can
subsequently control activities of second messengers such as cyclic nucleotides, inositol
phosphates, Ca2+ and the actin cytoskeleton leading to the cellular responses that mediate the
physiological response to the ligand. Upon the hydrolysis of GTP to GDP, the G protein cycle
terminates and the Gαβγ complex is reformed by the association between Gα-GDP and Gβγ
subunits [16].
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GPCR signaling in phototransduction
GPCR signaling is particularly important in the phototransduction cascade. Much of the
GPCR signaling pathway has been elucidated from the study of visual processing in the rod and
cone photoreceptor cells of the retina (Figure 1-2A). Therefore, the detailed signaling pathways
of GPCRs can be illustrated in the phototransduction processes (Figure 1-2B). Both rods and
cones have four primary structural regions, namely an outer segment, an inner segment, a cell
body and a synaptic terminus (Figure 1-2A) [26]. The visual pigment rhodopsin and other
phototransduction signaling components can be found in the dense membrane disks of the outer
segments. Besides serving as the main molecule of phototransduction, rhodopsin is also the
major structural component of the outer segment discs [27, 28]. The inner segment contains
mitochondria, endoplasmic reticulum and the Golgi apparatus and the cell body contains the
nucleus. The synaptic terminus can transmit neuronal signals from rods and cones to bipolar and
horizontal cells. In the absence of light, a steady inward cation conductance can be found on the
outer segment membrane, keeping the rods and cones in a depolarized state and maintaining a
steady synaptic release of glutamate. The inward dark current is controlled by the light-sensitive
cGMP-gated channels, whereas the outward current is regulated through the Na+/K+ ATPase [29,
30]. When light is absorbed, the cation conductance is blocked, producing a membrane hyperpolarization that terminates the release of glutamate, and this decrease in synaptic glutamate is
detected and processed by downstream retinal neurons for visual perception in the brain.
The chromophore, 11-cis-retinal, is covalently bound to rhodopsin through a Schiff-base
linkage to a conserved lysine residue (K296 in human rhodopsin) in the seventh transmembrane
helix [26]. In the absence of light, the 11-cis-retinal serves as a strong antagonist to lock the
rhodopsin in an inactive state [31, 32]. Upon photon absorption, the 11-cis-retinal is isomerized
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to all-trans-retinal. This
isomerization transforms
the retinal to a strong
agonist of rhodopsin [33].
Activated rhodopsin
associates with the
heterotrimeric G protein
transducin αβγ subunits
(Gt) and catalyzes the
exchange of GDP to GTP
on the transducin α subunit
(Gαt). As Gαt-GTP
dissociates from the
activated receptor and Gtβγ
dimers, it interacts with the

Figure 1-2. Organization of vertebrate retina and scheme of
phototransduction signaling.
A) The retina consists of rod and cone photoreceptors, bipolar cells,
ganglion cells, amacrine cells, horizontal cells and Müller glia as its seven
main classes of cell types, which form three distinct cell layers [5]. The
outer nuclear layer (ONL) of the retina refers to the photoreceptor cell
bodies. Upon stimulation, photoreceptor cells relay their signals via bipolar
cells, located in the inner nuclear layer (INL), to the ganglion cells. These
neuronal signals are transmitted from the ganglion cell layer (GCL) along
the optic nerve to the brain for visual processing. The amacrine cells and
horizontal cells in the inner nuclear layer form lateral connections and
regulate signaling pathways from rod and cone cells to the ganglion cells
[11]. A significant portion of amacrine cells can also be found in the
ganglion cell layer [13]. Müller glial cell bodies are formed in the center of
the inner nuclear layer and may also be engaged in the repair and
protection functions of retinal neurons. Reprinted from [14]. B) The G
protein signaling cycle in phototransduction is shown. Details of are
cascade is described in the text. Reprinted from [15].

cGMP phosphodiesterase (PDE) and activates the powerful cGMP hydrolysis activity of PDE.
PDE consists of two catalytic α and β subunits and two inhibitory γ subunits to form a tetrameric
protein complex [34, 35]. In the dark, the two PDEγ subunits inhibit the activity of the PDEαβ
subunits, but in the presence of light, Gαt-GTP associates with PDEγ and releases it from the
PDEαβ subunits to allow the hydrolysis of cGMP to take place. The rapidly decreased
cytoplasmic cGMP concentration results in the closure of cGMP-gated cation channels in the
plasma membrane of the photoreceptor outer segment within milliseconds [36] and
hyperpolarizes the membrane potential. This channel closure also reduces the cytoplasmic Ca2+
5

concentration because of decreased influx of Ca2+ through the channels. The reduction in
intracellular Ca2+ initiates a negative feedback to produce light adaptation.
Rapid recovery of the photoreceptor is critical for image processing. Activated rhodopsin is
shut down by phosphorylation events at its C-terminus mediated by rhodopsin kinase (GRK1)
and by the binding of visual arrestin to the phosphorylated rhodopsin to block further interaction
with Gt [37, 38]. GRK1 activity is mediated by recoverin [39-42], which is a calcium-binding
protein. In the presence of light, Ca2+ concentration decreases, and recoverin dissociates from
GRK1 to allow the phosphorylation of rhodopsin to take place. Moreover, all-trans retinal is
released from rhodopsin, forming the weakly active opsin form of the visual pigment.
Rhodopsin is regenerated through the binding of a new 11-cis retinal that is made through a
series of enzymatic reactions of the visual cycle that converts all-trans retinol back to 11-cisretinal in the retinal pigment epithelial cells and is subsequently transported to the photoreceptor
cells [43].
The rate limiting step of recovery of the light responses is the hydrolysis of GTP on Gαt by a
GTPase accelerating (GAP) complex. This GAP complex in the visual system consists of a
regulator of G protein signaling protein (RGS9-1), the Gβ5 subunit long isoform (Gβ5-L) and the
membrane-anchor protein (R9AP) [44-46]. The RGS9-1 protein has three domains, an RGS GAP
domain, a G protein γ-like (GGL) domain that associates with the Gβ5-L subunit and a DEP
(Dishevelled/Eg110/Pleckstrin) domain that binds to the plasma membrane anchoring R9AP
protein. The RGS9-1/Gβ5-L/R9AP GAP complex accelerates the hydrolysis of GTP in Gαt to
GDP resulting in the dissociation of Gα-GDP from PDEγ. PDEγ then reassociates with PDEαβ
subunits to inhibit the cGMP hydrolysis [47]. Since the concentration of the GAP complex is
higher in cones than in rods, it allows faster visual response in cone vision at high light intensity
6

[48, 49]. The reduction in PDE-mediated hydrolysis, coupled with light-induced activation of
guanylyl-cyclase (GC) restores cGMP levels. In the presence of light, the reduction in Ca2+
concentration causes dissociation of Ca2+ from the calcium-binding guanylyl-cyclase activating
protein (GCAP). The Ca2+-free GCAP can then activate GC. The activated GC rapidly restores
the cGMP concentration back to the basal level. Therefore, efficient recovery of the dark state
after a light response requires the inactivation of rhodopsin, Gαt and PDE, and the restoration of
cGMP concentration.
The role of phosducins in GPCR signaling
The visual system shows just how exquisitely GPCR signaling is controlled at different levels
within the cascade. This is the case for all GPCR signaling pathways. They can be inactivated at
the receptor level by phosphorylation, arrestin binding and internalization [22]. GPCR signaling
can also be regulated at the heterotrimeric G proteins level. Gα-GTP can be deactivated by
accelerating the hydrolysis of GTP through the action of RGS proteins [50, 51]. G protein βγ
subunits can be regulated by associating with Pdc [52-55] and PhLP1 [56, 57] to control the
amount of available Gβγ to interact with Gα-GTP or with other effectors. Pdc is expressed
mostly in the photoreceptor cells of the retina and in the pineal gland [52, 58], whereas PhLP1 is
expressed widely in most types of cells and tissues [59, 60] implying that PhLP1 has a more
general physiological function. However, the precise role of phosducins in Gβγ signaling has
been a long-standing challenge in GPCR signaling research.
Genetic components and expression of Pdc and PhLP1
A closer examination of the genetic structures of Pdc and PhLP1 have provided insight into
their physiological roles. The rat and human PhLP1 genes have been cloned and characterized to
7

determine the genetic composition and tissue expressions of PhLP1 [61]. Several splice variants
of PhLP1 have been discovered from PhLP1 mRNAs [59]. Isolated cDNAs of PhLP1 revealed a
long form (301 amino acids) and a short form (218 amino acids) of PhLP1. The PhLP1 gene
contains 4 exons and 3 introns in a similar order to the Pdc gene [62]. All introns contain
consensus sequences of donor and acceptor splice junctions that follows the 5'GT-AG-3' rule
[61]. The start codon of PhLP1 is located at exon 2, but additional alternative transcription
initiation sites have been found in other exons. There is 41% sequence identity and 65%
homology between PhLP1 and Pdc, yet the N-terminal domain of PhLP1 is shorter in Pdc [59].
A functionally important phosphorylation site is located in the N-terminus of PhLP1, which is
transcribed from the exon 2 and 3, and the thioredoxin-like structural domain is transcribed
mostly from exon 4 of the PhLP1 gene. The physical location of the PhLP1 gene has been
mapped to the human chromosome 9 and is linked to the genetic markes D9S1876 and D9S1674
(66-71cM), whereas the Pdc gene has been mapped to the human chromosome 1 [63]. Since
promoter regions of both PhLP1 and Pdc gene share little homology, it is believed that these two
genes have different gene expression regulatory mechanisms, which is consistent with the
differences in their tissue distribution. Full length PhLP1 is ubiquitously expressed in all tissues,
whereas Pdc is mainly expressed in retina and pineal gland [61]. Low level expression of Pdc has
also been described in other tissues [64]. Splice variants of PhLP1 have been detected in brain
and retina tissues, but they are expressed at a significantly lower level than the full length PhLP1
transcript [65]. PhLP1 is usually expressed at moderate levels in most tissues in the body, but a
high level expression of PhLP1 can be found in the adrenal gland [60, 66].
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Functional domains of Pdc and PhLP1
Phosducin and PhLP1 shares homologies on two independent domains [65]. X-ray
crystallographic analysis of Pdc has shown two domains that interact with Gβγ [3].
The N-terminal domains from both Pdc and PhLP1 form a helical structure and associate with
the loops on top of the WD repeat β-propeller of the Gβ subunit. This binding site is the same
region of Gβγ that interacts with Gα and other Gβγ-dependent effectors [67]. The C-terminal
domain forms a thioredoxin fold and binds outer strands of the β-propeller blades 1 and 7 of Gβ
[3, 68]. The Pdc-Gβγ crystal structure also reveals that the Helix 1,3 and C-terminal domain of
Pdc interact with three loops (287-295, 308-318, 329-338) of Gβγ and cause changes in the
conformation of these loops when compared to the Gαβγ structure [3]. These Gβγ binding
regions of Pdc are also conserved in PhLP1. Although both the N- and C-terminus of PhLP1 can
bind Gβγ, the N-terminus of Pdc/PhLP1 is responsible for most contact sites to the Gβγ subunits
[69-71]. The conformational changes of Gβγ upon binding to the N-terminal domain of Pdc
/PhLP1 creates a groove in Gβ and may facilitate the dissociation of Gβγ from the membrane
[52, 55], caused by burying the hydrophobic farnesyl moiety of the Gγ in that groove. The Cterminal domain of Pdc/PhLP1 can also prevent Gβγ from binding to the membrane by binding
to the β-propeller blades 1, 7 of Gβ where the farnesylated Gγ C-terminus is located for
membrane association [3, 72].
Assembly of the Gβγ dimer
Despite its ability to bind Gβγ, the physiological role of PhLP1 in G protein signaling was a
mystery for many years after its discovery in 1993 [59] until a vital function of PhLP1 in the
assembly of the Gβγ dimer was reported in 2005 [73]. The mechanism of folding and assembly
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of the Gβγ dimer had remained an enigma in the field for some time because the Gβ and Gγ
subunits are not stable in their monomeric form. Since Gβ cannot fold into a stable structure on
its own, Higgins and Casey suggested in 1994 that Gβ might need accessory proteins for its
assembly with Gγ [74]. Interestingly, while Gβ cannot be expressed and folded properly in the
bacterial expression system, the Gβγ dimer can be formed and formed in conditions where
heterotrimeric G proteins can be normally expressed such as in rabbit reticulocyte lysates [75]
and in insect cells [74], suggesting that additional accessory proteins may have co-evolved with
G proteins for the folding and assembly process of the Gβγ dimer. Subsequent studies set the
stage for the elucidation of the mechanism of Gβγ assembly. Genetic analysis of G protein
signaling in the chestnut blight fungus C. parasitica revealed that deletion of a gene named bdm1
phenocopied Gβ gene deletion [75]. This observation was critical because bdm1 gene is a
homolog of Pdc. However, the phenotype of bdm1 deletion in C. parasitica was contradictory to
the proposed role of Pdc, which at the time was believed to inhibit the G protein signaling by
associating with Gβγ and blocking its interaction with Gα [76]. A more detailed analysis
revealed that bdm1 is a closer homolog of PhLP1, which can also associate with a Gβγ dimer
like Pdc [77]. A major breakthrough toward resolving this dilemma occurred when our lab
discovered that PhLP1 was a binding partner for the cytosolic chaperonin containing tailless
polypeptide-1 complex (CCT) [73]. This breakthrough was first to link the Gβγ assembly
process to the protein chaperone system.

CCT-mediated protein folding
CCT is a large (~ 1 MDa) protein folding complex and belongs to a class of molecular
chaperones called class II chaperonins, which can form a holo-ring structure composed of many
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subunits. Chaperonins are classified into group I or group II chaperonins based on their
sequences and structures. Group I includes the eubacterial chaperone GroEL and mitochondrial
and chloroplast Hsp60 chaperonins. Group II includes archael chaperonins and CCT, which is
found in the cytoplasm of all eukaryotes [78]. GroEL chaperonin is formed by homodimerization
of one single subunit, whereas archaebacterial chaperonins are formed by oligomerization of two
homologous subunits. Both Group I and II chaperonins are necessary for sustaining homeostasis
of cellular proteins in the organisms in which they are expressed.
CCT is the most complicated of all chaperonins and consists of eight distinct homologous
subunits with each translated from individual genes. These eight CCT subunits α, β, γ, ε, ζ, η, θ
(CCT1-8 in yeast) can arrange in two octameric rings. These two rings stack back-to-back to
form a central folding cavity in each ring. The arrangement of each subunit in the chaperonin
ring seems to be fixed in a specific orientation [79]. It is estimated that approximately 5-10% of
newly synthesized cytoplasmic proteins, including many essential genes such as actin and
tubulin, require CCT for proper protein folding [80-82].
Group I and II chaperonin subunits share three common domains, namely an equatorial ATPbinding domain, an apical domain that allows substrate binding, and a central intermediate
domain that relays structural changes between the equatorial domain and the apical domain. The
apical domain sequence is the most divergent of the three domains, providing specificity for
substrate recognition and binding, whereas the equatorial and intermediate domains are more
conserved among different subunits of CCT [83]. Each equatorial domain contains an ATPbinding site and contact sites for interactions between neighboring subunits.
Each CCT subunit can bind ATP and uses the ATP hydrolysis energy to drive the protein
folding process [84, 85]. Although GroEL requires a lid-forming co-chaperone GroES for its
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folding, the crystal structure of a group II chaperonin from Thermoplasma acidophilum, termed
the thermosome, showed that the chaperonin complex contains an iris-like 'built-in' lid structure
formed by helical protrusions of the apical domain [86]. This lid structure can open and close
during the ATPase cycle of CCT and encapsulate substrates within the central folding cavity
[87]. Recent evidence has shown that initial ATP hydrolysis of one subunit in a ring can trigger a
ripple effect of ring closing in all other subunits. The folding cavity can provide an optimal
environment to minimize entropy and maximize folding potential of the nascent polypeptide to
allow protein folding into their native states [88].
In nucleotide-free conditions, apical domains of CCT are in an open conformation that
exposes substrate-binding sites [89-91]. ADP-AlFx [92, 93] mimics the trigonal-bypyramidal
transition state of the ATPase reaction and induces formation of lid closure [87], whereas ADPbound CCT is in an open state [94]. The ATP-binding action within the subunits of the ring
seems to be positively cooperative [95, 96], resulted in a concerted mode of action during lid
closure. In contrast, the inter-ring cooperativity seems to be negative, resulting in decreased
affinity for nucleotide binding in one ring while the other ring is occupied. Although most
studies have focused on analyzing CCT as a whole molecular complex, evidence has shown that
the CCT oligomer is dynamic and is capable of disassembling and reassembling under
physiological conditions and changes of ATP and potassium ions [97, 98]. Moreover, CCT
monomers may have activities themselves as monomeric subunits [99].
The complexity of CCT and its divergence in the apical domain allow CCT to recognize a
variety of substrates based on their sequence, structural geometry, and physical properties in the
context of protein biogenesis [100]. These interactions seem to be highly sequence-specific such
as the binding of actin and tubulin [10, 88]. Although most GroEL substrate recognition
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sequences are hydrophobic, CCT can bind to its substrates through hydrophobic or electrostatic
interactions with different motifs including polar and hydrophobic residues. Most CCT substrates
are large, hydrophobic, aggregation-prone proteins with regions of β-strand propensity [81, 101,
102]. Furthermore, many CCT substrates cannot be folded by other prokaryotic and eukaryotic
chaperones [103], and many CCT substrates are not found in bacterial genomes [104].
PhLP1 is not a substrate of CCT, but it interacts with CCT in its native form and regulates the
activity of CCT [57]. The cryo-EM structure of the dephosphorylated PhLP1-CCT complex
[105] revealed that PhLP1 is bound on top of the central cavity, making contacts with the tips of
the apical domains of CCT subunits. PhLP1 also spans the entire central cavity and constricts the
helical extensions of the apical domains, occluding the folding cavity. This structure is analogous
to the prefoldin-CCT structure in which prefoldin sits above the folding cavity to perform its cochaperone role in delivering actin and tubulin to CCT for folding [106]. It is also similar to the
GroES protein that forms a lid for GroEL to entrap its folding substrates. Interestingly, Pdc does
not share this CCT-binding ability with PhLP1 [57]. Therefore, this structural evidence
suggested that PhLP1 is a co-chaperone of CCT like prefoldin and GroES.

PhLP1 is an important co-chaperone in Gβγ assembly
While efforts in our lab were determining the interaction between PhLP1 and CCT, several
studies reported that WD40 repeat proteins such as Gβ were important CCT clients. A proteomic
analysis showed that yeast CCT interacts with proteins containing WD40 repeats; these show
weak sequence homology within an approximate 40 amino acid sequence ending in WD, and
folds into the blades of β-propeller structures. These β-propeller blades consist mostly of antiparallel β-strands [107, 108]; the folding process is believed to be difficult and to often require
chaperones for their folding due to the need for long-range contacts between β-strands that are
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hydrophobic and aggregation-prone [109]. Several WD40 repeat proteins have been found to
require CCT for their folding.
A genetic study in Dictyoselium showed that Gβ requires CCT and PhLP1 for folding deletion of PhLP1 mimics the phenotype of Gβ deletion [110]. Furthermore, Gβ and Gγ were not
able to associate with the plasma membrane in the absence of PhLP1 even though they could be
expressed individually, suggesting that the formation of Gβγ dimers was disrupted [110]. All of
these data pointed to the possibility that PhLP1 participates in Gβ folding and assembly of the
Gβγ dimer. Several experiments have provided evidence to support this hypothesis. First, in a
pulse-chase experiment, siRNA-mediated PhLP1 knockdown in HEK-293 cells resulted in a 5fold reduction in the rate of Gβγ assembly [73]. Second, an ectopically expressed PhLP1 Nterminal truncation (PhLP1 ∆1-75) variant lacking an essential Gβ-binding site in Helix 1
completely inhibited Gβγ assembly [3, 73]. Although this variant still binds CCT, its ability to
bind Gβ was greatly diminished. This variant competed strongly with endogenous PhLP1 to bind
CCT, but it was not able to bind Gβ and assist in Gβγ assembly. Thus, this variant was acting as
a strong dominant negative inhibitor of PhLP1 function by disrupting the assembly process.
Intriguingly, this PhLP1 ∆1-75 variant is similar to a splice variant of PhLP1 that occurs
naturally. This naturally occurring splice variant lacks the N-terminal 83 amino acids [59, 66],
but it is only expressed in low levels and in certain tissues, indicating that it may also be
involved in controlling Gβγ signaling. These experiments along with several other reports [111,
112] provided strong support for the hypothesis that PhLP1 can mediate Gβγ assembly.
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PhLP1 phosphorylation is important for mediating Gβγ assembly
Several studies have provided clues to the mechanism of PhLP1-mediated Gβγ assembly.
One study showed that ATP triggers the release of Gβ from CCT to form Gβγ dimers. No
association between Gγ and CCT was detected, suggesting that Gβ was released from CCT upon
binding to Gγ [113]. Another study has also shown that PhLP1 can form a ternary complex with
Gβ-CCT [114], and the CK2-mediated phosphorylation of PhLP1 at a triple serine sequence near
the N-terminal domain affects the stability the PhLP1-Gβ1-CCT complex [114].
PhLP1 phosphorylation at S18-20 by CK2 is a key event in the process of Gβγ assembly [66,
73, 114]. Based on mutagenesis data measuring the effect of S18-20 alanine substitutions on the
rate of Gβγ assembly, at least 2 of these 3 serines must be phosphorylated for PhLP1 to facilitate
the assembly of Gβγ effectively, and the S20 phosphorylation site is the most important residue
[114]. As a result, a PhLP1 S18-20A variant is an effective dominant negative inhibitor of
Gβγ assembly. Since PhLP1 ∆1-75 is also missing the S18-20 phosphorylation site and the
Gβ binding site, it is an even more potent inhibitor of Gβγ assembly than the S18-20A variant.
Both PhLP1 S18-20A and PhLP1 ∆1-75 variants can dramatically increase the binding of Gβ to
CCT due to the inability of these PhLP1 variants to [114] release Gβ from the CCT complex.
From this data, a model has been described for the folding of Gβ and its assembly with Gγ
(Figure 1-3). First, nascent Gβ polypetides bind CCT soon after synthesis on the ribosome to
prevent aggregation of Gβ [102]. PhLP1 then associates with Gβ-CCT to form a PhLP1-GβCCT ternary complex. If PhLP1 is phosphorylated at S18-20 by the protein kinase CK2, it
releases Gβ from CCT as a PhLP1-Gβ complex. It is possible that electrostatic repulsion
between the phosphates in S18-20 of PhLP1 and negatively charged residues on the apical
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domains of CCT is the driving force for the release of PhLP1-Gβ. Once released, Gβ can
associate with Gγ and form a PhLP1-Gβγ complex. The dimerized form of Gβγ is very stable
and can only be dissociated through denaturation [115]. Proper plasma membrane targeting of
heterotrimeric G proteins requires association between Gα and Gβγ subunits [116], so the Gα
subunit eventually binds to
the Gβγ subunits to form a
heterotrimer. In this
process, PhLP1 must be
displaced since PhLP1 and
Gα share a common
binding site on the Gβγ
subunits [65, 114]. The
displacement of PhLP1
allows it to participate in
subsequent rounds of Gβγ
dimerization. This model

Figure 1-3. A model of PhLP1-mediated Gβγ dimer assembly.
PhLP1 binds CCT and nascent Gβ to form a stable ternary complex.
Electrostatic repulsion between CK2-phosphorylated PhLP1 and CCT
triggers the release of PhLP1∙Gβ from CCT. The newly released
PhLP1∙Gβ then forms a complex with Gγ. Gα displaces PhLP1 and
associates with the Gβγ dimer allowing PhLP1 to engage in another cycle
of Gβγ assembly.

explains why G protein signaling is disrupted in cells depleted of PhLP1 because of the inability
to form Gβγ dimers [73].
Post-translational modification of G proteins subunits
After chaperone-assisted protein folding of Gβ and Gγ subunits, post-translational
modification of Gα and Gγ is required for the G protein subunits to be localized to membranes
properly [117]. After Gβγ is assembled, the C-terminus of Gγ subunits is prenylated with 15-
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carbon farnesyl or 20-carbon geranylgeranyl group through a thioester bond. This reaction is
mediated by a isoprenyl transferase enzyme that targets the carboxyl terminal CaaX motif of the
Gγ subunits [118]. For γ1, γ 9 and γ11, the serine at the X position codes for farnesylation,
whereas the other Gγ subunits have leucine at the X position and codes for geranylgernaylation
[116]. This modification greatly increases the association of Gβγ with lipid bilayers.
Gα is also anchored to the membrane through lipid modifications. Gα subunits of the
Gαi family, including Gαi, Gαo, Gαz, and Gαt subunits are all myristoylated, which is the
attachment of the 14-carbon fatty acid myristate group to a glycine at the N-terminus of the Gα
protein. This reaction is catalyzed by the enzyme N-myristoyl transferase (NMT) [119]. In
addition, a 16-carbon fatty acid palmitate group is attached to one or more cysteine residues
within N-terminal 20 amino acids of all the Gα subunits through a thioester bond for all Gα
subunits with the exception of Gαt. The palmitoylation is reversible, but the myristoylation is
irreversible [116]. Once the Gαβγ heterotrimer is formed and post-translationally modified, the
heterotrimer is trafficked to the plasma membrane, most likely in a complex with a GPCR [116].

Specificity of PhLP1-mediated Gβγ assembly
Most studies on Gβγ assembly have concentrated on a common Gβγ pair, the Gβ1γ2 dimer.
Since there are five isoforms for Gβ and twelve isoforms for Gγ, it was not clear whether all
these isoforms were assembled similarly. Gβ1 and Gβ4 both form dimers with all Gγs, whereas
Gβ2 and Gβ3 only interact with specific Gγ isoforms [120]. All Gβ and Gγ subunits are obligate
dimers and are irreversibly associated, with the exception of the Gβ5 subunit [116]. Gβ5 does not
associate with Gγs but instead interacts with the RGS subfamily 7, which consists of RGS6, 7, 9
and 11 [121]. Gβ5 can bind a Gγ-like (GGL) domain on RGS7 similar to the binding of other
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Gβs to Gγ [7]. The Gβ5-RGS complex is the principal GAP for GTP hydrolysis of Gα subunits
in neuronal cells [121].
A comprehensive study was carried out to study the role of PhLP1 in assisting the assembly
of different Gβγ and Gβ5-RGS combinations [122]. PhLP1 binds all five isoforms of Gβ. Gβ1-4
bound similarly to PhLP1, whereas Gβ5 bound PhLP1 ~4 fold weaker than the other Gβs.
Moreover, 70% siRNA-mediated PhLP1 knockdown resulted in a 70-80% decrease in assembly
between Gβ1-4 and Gγ2 [122]. Furthermore, over-expression of the dominant negative PhLP1 ∆175 variant has reduced the assembly between Gβ1-4 and Gγ2 by 80-90%, supporting the idea that
PhLP1 mediates the assembly of all Gβ1-4 isoforms that dimerize with Gγs.
In reciprocal experiments, siRNA-mediated PhLP1 knockdown or PhLP1 ∆1-75 variant overexpression inhibited assembly between Gβ2 and all twelve Gγ isoforms by ~80% [122]. Another
recent study also showed that Gβ1-4 can bind CCT, and the assembly of Gβ1γ2, Gβ1γ3 and Gβ2γ3
required CCT [113]. All this evidence supports the notion that PhLP1 functions as a cochaperone of CCT for assembly of all Gβγ combinations. Moreover, the effects of PhLP1 did not
discriminate the combinations of Gβ2γx, as evidenced by the fact that siRNA knockdown or
PhLP1 ∆1-75 overexpression consistently inhibited Gβγ assembly by ~80% regardless of the
original extent of Gβγ dimer formation. The results of this study indicate that PhLP1 does not
specify the combinations of Gβγ assembly but only assists in the association of Gβγ subunits that
can form stable dimers. Moreover, the stability of Gβ2γx dimers can be classified distinctively
into Gγ subfamilies, indicating that the amino acid sequence of the Gγ subunit can determine the
specificity of the Gβ2 and Gγ subunit interactions due to the complementarity of their binding
surfaces [122].
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Assembly of Gβ5-RGS7 signaling complex
The GGL-domain of RGS9 occupies the same contact site on the Gβ5 β-propeller as does Gγ1
[7] (Figure 1-4), suggesting
that the Gβ5-RGS complex
may be assembled by a similar
mechanism as Gβγ. However,
Gβ5 associates with CCT and
PhLP1 with much lower
affinity than Gβ1 does [113,
114], suggesting that the
mechanism for Gβ5-RGS
assembly might be
significantly different from

Figure 1-4. The atomic structures of Pdc-Gβγ and Gβ5-RGS9
complexes.
PhLP1 is predicted to compete with the DEP/DHEX domain of the Nterminal domain in RGS9 to bind Gβ5. The overlapping binding site
hinders the association between PhLP1 and the Gβ5-RGS dimer. Color
code of individual molecules: phosducin – teal, Gβ1 – blue, Gγ – red,
Gβ5 – dark blue, RGS DEP/DHEX domain – magenta, RGS Gγ-like
domain – dark red, RGS domain – orange. PDB numbers for the
structures: Pdc-Gβγ (1A0R) [3] and Gβ5-RGS9 (2PBI) [7].

Gβγ. To test this idea, the role of PhLP1 and CCT in the process of Gβ5-RGS7 assembly was
assessed in the HEK-293 cell cultures [122]. A two-fold reduction in the rate of Gβ5-RGS7
assembly was achieved by an 80% siRNA-mediated PhLP1 knockdown. This reduction in
assembly rate was less than the five-fold decrease with Gβ1γ2 assembly under the same
conditions [73, 114]. Moreover, 50% knockdown of CCT by siRNA has resulted in a two-fold
decrease in both the assembly rates of Gβ5-RGS7 and Gβ1γ2, suggesting that Gβ5-RGS7
assembly is dependent on CCT but perhaps less dependent on PhLP1.
Several additional experiments were performed to determine the role of PhLP1 in Gβ5-RGS7
assembly. First, over-expression of wild type PhLP1 caused a ~25% reduction in the rate of Gβ5-
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RGS7 assembly. This effect
was in contrast to the 4-fold
increase in Gβ1γ2 assembly
under the same conditions
[73, 114]. Second, overexpression of PhLP1
resulted in a 10-fold increase
in the amount of Gβ5
binding to CCT regardless of
whether RGS7 was coexpressed or not. This
observation was also in
contrast to the effects of

Figure 1-5. Proposed mechanism of Gβ 5-RGS7 assembly.
Gβ5 associates with CCT weakly but is not able to fold into its native state
in the absence of PhLP1. PhLP1 stabilizes the Gβ5-CCT complex and
assists Gβ5 to fold into its native state. Phosphorylation of PhLP1 and ATP
hydrolysis on CCT allows PhLP1 to be released from the PhLP1-Gβ5-CCT
complex. After the release of PhLP1, RGS7 then interacts with the folded
Gβ5 on CCT via its N-terminal DEP/DHEX domain [7]. Upon association,
the Gβ5-RGS7 complex can be released from CCT as a functional dimer.

PhLP1 over-expression in enhancing the release of Gβ1 from CCT [114].
These differences in the roles of PhLP1 in the assembly of Gβ5-RGS and Gβγ can be
explained by the way PhLP1 is binding to these dimers. PhLP1 binds Gβ1γ2 and Gβ5γ2 with a
dissociation constant of 100 nM and 440 nM, respectively, whereas the binding of PhLP1 to
Gβ5-RGS complex was undetectable [122]. These binding differences can be explained by
structural analysis of the Pdc-Gβγ and Gβ5-RGS9 complexes. As described previously, Pdc can
bind Gβγ on the same contact site as Gα. This site is on the opposite side of the Gβ subunit βpropeller that Gγ binds [3]. Since PhLP1 shares extensive homology with Pdc, it is likely that
PhLP1 also binds Gβγ like Pdc. Therefore, PhLP1 can still bind Gγ-associated Gβ. In contrast,
The DEP/DHEX domain of the N-terminal lobe of RGS9 interacts with Gβ at the side as PhLP1
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[7], precluding the formation of a PhLP1-Gβ5-RGS9 complex due to the overlapping binding
sites. Accordingly, it appears that PhLP1 must be released from Gβ5 subunit prior to the
association of Gβ5 with RGS.
A model based on the current data to depict the role of PhLP1 in Gβ5-RGS assembly is shown
in Figure 1-5. In both models of Gβγ and Gβ5-RGS assembly, CCT is required for the folding of
Gβ subunit. PhLP1 stabilizes the interaction between Gβ5 and CCT to enhance substrate folding.
PhLP1 is released from the Gβ5-CCT complex before Gβ5 can associate with RGS, whereas
PhLP1 can still bind to Gβ in the presence of Gγ. The need for PhLP1 to stabilize the Gβ5-CCT
complex coupled with the requirement for PhLP1 release prior to Gβ5-RGS assembly can
explain why Gβ5-RGS7 assembly was decreased by either increasing or decreasing the cellular
level of PhLP1. This model also suggests that Gβ5 can associate with RGS while binding to
CCT. The basis for this prediction is the observation that RGS was recruited to CCT by Gβ5,
leading to the formation of RGS7-Gβ5-CCT ternary complex intermediate [122]. Previous
evidence has shown that RGS7 can interact with Hsc70 [123, 124], suggesting that Hsc70 can
deliver nascent RGS proteins to the Gβ5-CCT complex. After the Gβ5-RGS complex is formed,
it can be released from CCT to interact with membrane anchoring proteins and eventually
becomes fully stabilized to assist in accelerating GTP hydrolysis on Gα subunits [125].
Physiological roles of other phosducin family members
The phosducin gene family is conserved among organisms ranging from single cell
eukaryotes to mammals. This gene family can be classified into three subgroups [110]. Subgroup
I consists of Pdc and PhLP1, subgroup II is composed of PhLP2A and PhLP2B [110, 126, 127],
and subgroup III is represented by PhLPII. The physiological functions of the subgroup II and III
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genes have not been thoroughly investigated. Nonetheless, PhLP2A is essential for cell growth in
yeast Saccharomyces cerevisiae [128] and the soil amoebae Dictyostelium discoideum [110].
PhLP3 is believed to be involved in β-tubulin and actin folding [129, 130]. Although these
members of the phosducin gene family seem to have diverse cellular functions, most evidence
supports a role for PhLP1-3 as co-chaperones in protein folding while Pdc may be unique in its
function in regulating Gβγ signaling in the phototransduction processes.
Conclusion
Since GPCRs regulate a large variety of physiological processes, it is vitally important to
regulate GPCR signaling at different levels. Pdc and PhLP1 of the phosducin family serve
different roles in regulating the GPCR signaling in the retina and other tissues in mammals.
Recent studies have firmly established the physiological role and significance of PhLP1 as a
molecular co-chaperone with CCT to mediate Gβγ assembly. Although a general mechanism of
Gβγ assembly has been postulated, many of the mechanistic details about this process are still
missing. Structural analysis of each intermediate step in CCT-assisted Gβ folding can generate
snapshots of the assembly process and provide an accurate account of the mechanism beyond
current understanding. Therefore, we have embarked on an endeavor to determine the structures
of two key intermediates, CCT-Gβ1 and CCT-Gβ1-PhLP1, in the Gβγ assembly process.
Structural information of these complexes will also allow us to understand the interactions
between CCT, Gβ1, and PhLP1 by providing the molecular details of the Gβγ assembly process.
These details provide the foundation for the development of therapeutics to control Gβγ
assembly and thereby regulate G protein signaling.
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CHAPTER 2:
STRUCTURES OF THE Gβ1-CCT AND PHLP1-Gβ1-CCT COMPLEXES REVEAL
INSIGHTS INTO THE MECHANISM OF Gβγ ASSEMBLY
Summary
G-protein coupled receptor signaling is essential for many physiological processes. Since the
regulation of these responses is vitally important, GPCR signaling pathways are carefully
controlled at different levels within the cascade. The phosducin-like protein 1 (PhLP1) can bind
the G protein β subunit and contribute to GPCR signaling. Recent evidence has supported the
concept that PhLP1 serves as a co-chaperone of the eukaryotic cytosolic chaperonin complex
(CCT/TRiC) and forms a ternary complex with the Gβ1-CCT complex to mediate Gβγ assembly.
CCT/TRiC plays a crucial role in the folding of many essential proteins. Here we show threedimensional reconstructions of the Gβ1-CCT and the PhLP1-Gβ1-CCT complexes assembled in
vivo. An electron microscopic analysis reveals that Gβ1, representing the WD40 repeat proteins
which are a major class of CCT substrates, interacts specifically with the apical domain of
CCTβ. Gβ1 binding experiments with several chimeric CCT subunits confirm a strong
interaction with CCTβ and map Gβ1 binding to a hydrophobic core of amino acids located in αHelix 9 and in the loop between β-strands 6 and 7, facing the chaperonin cavity. Fitting the Gβ
molecule into the two 3D reconstructions (Gβ1-CCT and PhLP1-Gβ1-CCT) reveales that upon
PhLP1 binding to Gβ1-CCT, the quasi-folded Gβ molecule is constricted to a native state and
shifted to an angle that can lead to the release of folded Gβ1 from CCT. Moreover, mutagenesis
of the CCTβ subunit suggests that PhLP1 can interact with the tip of the apical domain of the
CCTβ subunit at residue S260, which is a downstream phosphorylation target site of activated
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RSK and S6K from the Ras-MAPK and mTOR pathways. Together, these results reveal a novel
mechanism of PhLP1-mediated Gβ folding and its release from CCT.
Introduction
GPCR signaling pathways regulate a large variety of physiological responses such as
vision, cardiac rhythm, taste, growth, neuronal signals [15, 21, 22], and the malfunctioning of
these signaling processes can lead to devastating diseases such as cancer, heart disease, vision
impairment, neural diseases, and hypertension [16-20]. Many different ligands such as small
molecule neurotransmitters, peptide hormones, chemokines, lipids, odorants and even photons of
light can trigger the activation of GPCR signaling and in turn initiate the signaling processes
through the intracellular G proteins. Upon binding of a ligand to the extracellular domain of a
GPCR, a conformational change takes place in the packing of the seven transmembrane αhelices of the activated GPCR. This conformational change propagates to the intracellular
surface of the GPCR and activates heterotrimeric G proteins that associate with the receptor.
This activation process promotes the exchange of GDP for GTP on the G protein α subunit (Gα)
and leads to the dissociation of Gα-GTP from the G protein βγ subunits (Gβγ). Gα-GTP and
Gβγ in turn regulate the activity of effector enzymes and ion channels that mediate the cellular
response to the ligand. Upon the hydrolysis of GTP to GDP, the G protein cycle terminates and
the Gαβγ complex is reformed with the reassociation of Gα-GDP with Gβγ [16]. Since the
regulation of these physiological responses is critical, GPCR signaling pathways are carefully
controlled at different levels within the cascade. Gβγ signaling can be regulated by associating
with Pdc [52-55] and PhLP1 [56, 57] to control the amount of available Gβγ to interact with GαGTP or with other effectors. Recent studies have shown that the PhLP1 can serve as a co-
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chaperone of the chaperonin containing tailess complex polypeptide 1 (CCT) to facilitate Gβγ
signaling [57, 73, 105, 114].
CCT is a group II chaperonin family. Group I chaperonins are found in prokaryotes and
eukaryotic organelles of endosymbiotic origin and whose best characterized member is GroEL
from E. coli [131]. GroEL and the rest of the Group I chaperonins have a double heptameric ring
structure and assist protein folding through cooperation with a small heptameric co-chaperonin
termed GroES in E. coli [132], which acts as a lid, isolating the unfolded protein in the
chaperonin cavity. Group II chaperonins, found in eukaryotes and archaea, share an overall
architecture with their bacterial counterparts, but they differ from them in several aspects [133].
First, they are composed of 1-3 different subunits and form either octameric or nonameric double
ring structures. Second, they lack a co-chaperone that acts as a lid but instead rely on an
additional structure, a built-in helical protrusion, which also caps the chaperonin cavity and
isolates the unfolded protein in its interior.
The eukaryotic cytosolic chaperonin CCT (Chaperonin Containing TCP-1; also termed TRiC)
is the most complex of all chaperonins [134]. This complexity is due not only to the fact that it is
composed of 8 different but homologous subunits, but also that its mechanism seems to be very
different from the other chaperonins. Whereas the folding mechanism of GroEL (and probably of
the archaeal group II chaperonins, also named thermosomes) relies on non-specific, hydrophobic
interactions between residues of the chaperonin apical domains and the unfolded polypeptide
[80, 135], the folding mechanism of CCT seems to be based on specific interactions between
charged and polar residues located in particular regions of the unfolded protein and specific CCT
subunits [134]. This has been shown to be the case for the major CCT substrates, the cytoskeletal
proteins actin and tubulin [85, 136]. However, recent studies have shown that hydrophobic
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interactions are involved in the direct association of CCT with several substrates. This is the case
for the tumor suppressor protein VHL [137] and the G protein β1 subunit (Gβ1) [102].
Gβ1 is a member of the WD40 repeat family of proteins, a large group defined by the
presence of a β-propeller structure. They exhibit a high degree of functional diversity, although
many of them are involved in protein-protein interactions that anchor multi-subunit complexes
[104]. Early proteomic studies of the yeast interactome revealed interactions of many WD40
proteins with CCT [134], and further analysis of the CCT interaction network identified a
propensity for large β-sheet structures among CCT substrates, including WD40 proteins [81]. In
addition to Gβ, other WD40 proteins that have been shown to be CCT substrates include Cdc20
and Cdh1, which are part of the anaphase promoting complex that plays a key role in cell cycle
progression [101]. The atomic structure of Gβ is known [68] and consists of a seven-bladed β
propeller, each blade formed by a WD40 motif consisting of four antiparallel β-strands, and a
small N-terminal α-helix. The folding of Gβ is a complex process that is initiated by an
interaction with CCT [113, 114].
Recent structural and biochemical studies have supported a model in which PhLP1 acts as a
co-chaperone that is required for the release of Gβ from CCT and its subsequent association with
Gγ [73, 114]. In this model, nascent Gβ polypetides bind CCT soon after polypeptide synthesis
to prevent aggregation of Gβ [102]. PhLP1 then associates with Gβ-CCT to form a PhLP1-GβCCT ternary complex. If PhLP1 is phosphorylated at three consecutive serine residues near its
N-terminus (S18-20) by the protein kinase CK2, it releases Gβ from CCT, possibly because of
electrostatic repulsion between the phosphates in S18-20 of PhLP1 and negatively charged
residues on the apical domains of CCT. This repulsive force may result in the release of a
PhLP1-Gβ intermediates that can associate with Gγ and form a PhLP1-Gβγ complex. The Gα
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subunit then binds to the Gβγ subunits to form a heterotrimer. In this process, PhLP1 must be
displaced since PhLP1 and Gα share a common binding site on the Gβγ subunits [65, 114]. The
displacement of PhLP1 allows it to participate in subsequent rounds of Gβγ dimerization.
Although a model of PhLP1-mediated Gβγ assembly has been postulated, the mechanism by
which the Gβ subunit is assisted by PhLP1 to fold into its native state and release from CCT
remains unclear.
To understand the structural basis for PhLP1-mediated Gβγ assembly, we have isolated two
important intermediates in the assembly process, the Gβ1-CCT and PhLP1-Gβ1-CCT complexes
that were assembled in vivo in insect cells, and have determined their structures by cryo-electron
microscopy (cryo-EM). The structures show that Gβ folds into a quasi-native form in the CCT
folding cavity in the absence of PhLP1 and that the association with PhLP1 closes the Gβ structure
and shifts it in the CCT folding cavity, suggesting that PhLP1 stabilizes the native form of Gβ and
changes its binding contacts with CCT to permit the release of Gβ from CCT.
Experimental Procedures
Gβ1 and PhLP1 baculovirus preparation
Human Gβ1 and PhLP1 cDNA were cloned into the pBlueBac4.5/V5-His-TOPO vector
(Invitrogen Cat: K2100-20) following the manufacturer’s protocol with slight modifications. In
brief, PCR was used to add a C-terminal HPC4 tag (protein C epitope) along with flanking
BamHI (5′) and AgeI (3′) restriction sites to the human Gβ1 cDNA sequence. For PhLP1, a Cterminal His-TEV-Myc tag along with flanking BamHI (5′) and XbaI (3′) restriction sites was
added to the human PhLP1 cDNA sequence (Figure 2-1). The PCR products were introduced
into the pBlueBac4.5/V5-His TOPO vector at their corresponding restriction sites using standard
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cloning techniques. The Gβ1-HPC4-pBlueBac4.5
and the PhLP1-TEV-myc-His-pBlueBac4.5 vector
were co-transfected into Sf9 cells with the Bac-NBlue vector (Invitrogen) to facilitate
recombination for the generation of recombinant
virus. The successfully recombined baculoviruses
were identified by lacZ screening and were

Figure 2-1. Design of PhLP1-TEV-Myc-His
& Gβ 1-HPC4 for protein expression.
The recombinant proteins PhLP1 and Gβ
were co-expressed in insect cells using the
baculovirus expression system. The PhLP1
construct contains the TEV protease
recognition site for tag removal, the Myc-tag
for potential antibody-affinity isolation and
the His-tag for metal-chelate affinity
purification. The Gβ construct contains the C
peptide epitope sequence for the HPC4
antibody column affinity purification.

isolated using plaque assays. The presence of the
Gβ1-HPC4 or PhLP1-TEV-myc- His insert was confirmed by PCR and sequencing. The correct
clones that express baculovirus were amplified in Sf9 cells to produce high-titer stocks of
baculovirus for expression experiments.
Purification of Gβ1-CCT and PhLP1-Gβ1-CCT complex
Hi5 cells (Invitrogen) were grown on EX405 insect cell medium (Sigma Aldrich). For
expression of recombinant PhLP1 and/or Gβ1 proteins, Hi5 cells were transfected with
corresponding baculovirus at an MOI of ~10 and were harvested 72-84 hrs after transfection.
Portions of each sample were immunoblotted to confirm recombinant protein expression. Cells
were collected by centrifugation at 3,500 g for 15 min and pellets were stored at - 80 ºC. To
extract total soluble proteins for Gβ1-CCT purification, cell pellets were resuspended in 3.2 ml
HP-Resuspension Buffer (20 mM HEPES pH 7.5, 20 mM NaCl) per gram of cell pellet. For
purification of PhLP1-Gβ1-CCT complex, cell pellets were resuspended in 3.2 ml Coresuspension Buffer (20 mM HEPES pH 8.0, 20 mM) per gram of cell pellet. Protease inhibitors
(PMSF 0.5 mM and protease inhibitor cocktail 6 mg/ml (Sigma Aldrich)) were added to the
solution, and the cells were lysed by two freeze-thaw cycles in liquid nitrogen and a 37 ºC water
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bath (~ 10 min). 24 U/mL of Benzonase nuclease was added to cell extracts to digest genomic
DNA into small fragments. Cellular debris was cleared by centrifuging at 20,000 g for 15 min. In
addition, 0.05% CHAPS was added to the cell extracts to stabilize the PhLP1-Gβ1-CCT
complex. All subsequent purification steps were performed at 4 ºC.
For purification of the Gβ1-CCT complex, the cell extract was layered on top of a sucrose
cushion of 10 ml/tube 1 M sucrose in 20 mM HEPES pH 7.5, 20 mM NaCl, 0.5 mM PMSF, 6
µl/ml protease inhibitor cocktail in Beckman polyallomer ultracentrifuge tubes (26 x 77 mm).
The samples were centrifuged at 93,000 g (30,000 rpm) for 2 hrs. The bottom of the tube was
pierced and ~ 8 ml was collected from the sucrose layer, while the rest was discarded. This
fraction was diluted 1:1 with HP-Resuspension Buffer and CaCl2 (2 mM) and CHAPS (0.05%)
were added. The sucrose cushion product was loaded onto a HPC4 column for further
purification.
For the purification of the PhLP1-Gβ1-CCT complex, the cell extracts were loaded directly
into an equilibrated (20 mM HEPES pH 8.0, 20 mM NaCl, 0.05% CHAPS) HisPur Cobalt
column. The cobalt column was then washed 3 times with Co-wash buffer (20 mM HEPES pH
8.0, 20 mM NaCl, 0.05% CHAPS). The cobalt column was eluted with 3 fractions of 1 column
volume of Co-EL buffer (20 mM HEPES pH 7.5, 20 mM NaCl, 2 mM CaCl2, 0.05% CHAPS,
500 mM imidazole) with 10 min. incubation time between each elution. The cobalt column
product was loaded onto an HPC4 column for further purification.
The sucrose cushion product for Gβ1-CCT purification and cobalt column product for the
PhLP1-Gβ1-CCT purification were further purified on an HPC4 affinity column. The solutions
were passed twice through a 5 ml immobilized HPC4 antibody column equilibrated in HP-EQ
buffer (20 mM HEPES pH 7.5, 20 mM NaCl, 2 mM CaCl2, 0.05% CHAPS). For the Gβ1-CCT
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purification, the column was washed 5 times with 7 ml of HP-high salt wash buffer (20 mM
HEPES pH 7.5, 500 mM NaCl, 2 mM CaCl2) and one additional wash with 7 ml of HP-EQ
buffer. For the PhLP1-Gβ1-CCT purification, the HPC4 column was washed 3 times with 5 mL
of HP-wash buffer (20 mM HEPES pH 7.5, 250 mM NaCl, 2 mM CaCl2) and one additional
wash with 5 mL of HP-EQ buffer. The product was eluted by adding 5 mL of HP-EL buffer (20
mM HEPES pH 7.5, 20 mM NaCl, 10 mM EDTA) to the column and incubating for 30 min
before collection. This elution step was repeated 3 more times with 5 min incubations before
each collection. The eluted complexes were concentrated to ~ 200 µl using a 15 ml (10 MWCO)
Vivaspin concentrator (Sartorius Stedim Biotech), 10-20% glycerol was added and the sample
was stored at – 20oC until cryo-EM analysis was performed. The purified complexes usually
reached 95% or higher purity as estimated by SDS-PAGE.
The composition of the insect PhLP1-Gβ1-CCT complex was determined by mass
spectrometry. A portion of the purified complex was denatured in urea, alkylated with
iodoacetamide and digested with trypsin. The resulting peptides were analyzed by LCMSMS
using an LTQ Orbitrap XL instrument. The MSMS data were analyzed using the Mascot search
engine [138] against the Drosophila melanogaster genome database and the human Gβ1 and
PhLP1 sequences. The Drosophila genome is the closest sequenced genome to that of the Hi5
cells, which are derived from the Cabbage Looper moth, Trichoplusia ni. The presence of
PhLP1, Gβ1, CCTα, β and ζ in the complex was confirmed by immunoblotting with anti-PhLP1
[139], anti-Gβ1 antibody, or anti-CCT monoclonal antibodies (CCTα 91A, CCTβ 4E217 and
CCTζ1Α4). In addition, the phosphorylation state of purified PhLP1-Gβ1-CCT was determined
by treating with alkaline phosphatase and measuring the phosphorylation-dependent mobility
shift in SDS-PAGE.
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Preparation of cDNA constructs
The pcDNA3.1 myc-His B+ vector was used for all constructs. N-terminal myc-tagged
human PhLP1 was constructed previously [73]. C-terminal FLAG-tagged human α-tubulin was
constructed using standard PCR and cloning techniques. N-terminal FLAG-tagged human Gβ1
was obtained from the Missouri University of Science and Technology cDNA Resource Center.
Wild type human VHL, CCTβ, CCTδ were obtained from Open Biosystems. CCT constructs
were internally HA-tagged (sequence including linker amino acids: GSGYPYDVPDYAGSG) at
a loop on the exterior of the apical domain (after G368 of CCTβ and G383 of CCTδ) using
standard PCR and cloning techniques. CCT chimeras were created by substituting amino acids of
one CCT subunit with the same amino acids of another CCT subunit (see Fig. 2-7). Chimera
design included some discontinuous residues to avoid disrupting secondary structure created by
Pro residues. Alanine variants were created by site-directed mutagenesis using standard PCR
methods.
Cell culture and transfection
HEK-293T cells were cultured in Dulbecco’s modified Eagle’s medium/Ham’s F-12 (1:1)
growth media containing 2.5 mM L-glutamine and 15 mM HEPES and supplemented w/ 10%
fetal bovine serum. Cells were subcultured regularly but not beyond 25 passages. For
transfection, cells were plated in 6-well plates or 60 mm dishes to 90-95% confluency and
transfected using Lipofectamine 2000 (Invitrogen), according to the manufacturer’s protocol. For
CCT incorporation and binding experiments, cells in 60 mm dishes were transfected using 6 μg
DNA (3 μg FLAG-Gβ1, FLAG-α-tubulin, FLAG-VHL, Myc-PhLP1 or empty vector control as
indicated and 3 μg HA-tagged CCT subunit) and 6 μl Lipofectamine 2000. Cells were fed 12-24
hours post-transfection and harvested 42-48 hours post-transfection.
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Binding to CCT variants
The binding of Gβ1, α-tubulin, VHL, or PhLP1 to the HA-tagged CCT variants was
determined by co-immunoprecipitation. Transfected HEK-293T cells were washed twice with
phosphate-buffered saline (Fisher) and harvested in immunoprecipitation (IP) buffer (phosphatebuffered saline pH 7.4, 1-2% Nonidet P-40 (Sigma Aldrich), 0.6 mM PMSF, and 6 μl/ml
protease inhibitor cocktail (Sigma Aldrich P8340)). Lysates were triturated 10 times through a
25-gauge needle and centrifuged at 14,000 rpm for 10-12 min at 4°C in an Eppendorf microcentrifuge. Protein concentrations were determined using the DC Protein Assay Kit II (Bio-Rad),
and approximately equal amounts of protein were used for each sample in the
immunoprecipitation. Roughly 450 μg of total protein were used for immunoprecipitation with
cells from 6-well plates and 1,000 μg with cells from 60 mm dishes. Clarified lysates from 6well plates were incubated for 1 hr at 4°C with 1 μg anti-HA antibody (clone 3F10, Roche
Applied Science), followed by incubation for 1 hr at 4°C with 30 μl of a 50% slurry of Protein
A/G Plus-agarose (Santa Cruz Biotechnology). Lysates from 60 mm dishes were incubated for 13 hrs at 4°C with 1.5 μg anti-HA and 1 hr at 4°C with 50 μl of a 50% slurry of Protein A/G Plusagarose. Beads were then washed three times with 500 μL IP buffer, and immunoprecipitated
proteins were solubilized in SDS sample buffer and resolved using 10% SDS-PAGE. For αtubulin immunoprecipitation, an additional 250 mM NaCl was also added to buffers during
incubation and wash steps. Proteins were transferred to nitrocellulose and immunoblotted using
anti-PhLP1, anti-FLAG (clone M2, Sigma), anti-HA (Roche Applied Science), anti-CCTδ (AbD
Serotec), or anti-CCTε (AbD Serotec) antibodies. Corresponding anti-rabbit, anti-mouse or antirat secondary antibodies labelled with the near infrared fluorescent dye 800 CW (LiCor
Biosciences) were used, and blots were scanned using the Odyssey Infrared Imaging System (Li-
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Cor Bioscience). Protein band intensities were quantified using the Odyssey software. Binding
was determined by calculating the ratio of the FLAG-substrate or PhLP1 band to the HA-CCT
band for each variant and normalizing the ratio to that of wild-type CCT.
Electron microscopy
For EM, 5 µl aliquots of the Gβ1-CCT or PhLP1-Gβ1-CCT complexes were applied to glowdischarged carbon grids for 1 min. Samples were stained for 1 min with 2% (w/v) uranyl acetate.
Images were recorded at 0º tilt in a JEOL 120GX- II electron microscope, operated at 100 kV, on
Kodak SO-163 film at 60,000x nominal magnification. For Cryo-EM, 5 µl aliquots of the Gβ1CCT or PhLP1-Gβ1-CCT complexes were applied to glow-discharged Quantifoil 1.2 µm holey
carbon grids for 1 min, blotted for 3 s and frozen rapidly in liquid ethane at -180ºC. Low-dose
images (<10e- A-2) of complexes were taken on a FEI Tecnai G2 FEG200 electron microscope
at 200 kV using a Gatan side-entry cryo-holder with a nominal magnification of 62,000x and
1.8-3.0 µm underfocus.
Image processing
Micrographs were digitized in a Zeiss SCAI scanner with a sampling window corresponding
to 3.5 Å pixel-1 for negatively stained samples and 4.2 Å pixel-1 for vitrified samples. Twodimensional classification of the negative-stain data was performed using maximum-likelihood
procedures [140]. For the three-dimensional reconstruction of the frozen-hydrated data, samples
were processed without any a priori assumption. First, images were classified into homogenous
groups using reference-free methods (refine2d.py command in EMAN [141], and maximumlikelihood approaches implemented in XMIPP) and selected averages were used to build
reference volume using common lines. After several rounds of refinement without symmetry
imposition, an extra mass inside the CCT cavity appeared. These structures were calculated from
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images selected by EMAN and were subsequently used for a further refinement using projectionmatching protocols implemented in the SPIDER package [142]. The resolution of the final
structures was estimated with the 0.5 criterion for the Fourier shell correlation coefficient
between two independent reconstructions by using BSOFT [143]. The density map and atomic
structures were visualized with UCSF Chimera [4]. The threshold was chosen to account for
approximately 100% of the protein mass. The atomic structures of Pdc-Gβ1 [3] and the CCT
subunits from the open conformation of the mammalian tubulin-CCT crystal structure [1] were
manually fitted with the EM density, and the handedness providing the best fit was chosen to
render the EM reconstruction.
Sequence alignment
Sequence alignments of the apical domain of the eight human CCT subunits and of the CCTβ
apical domain from various eukaryotes were performed using the ClustalX2 algorithm version
2.0.12 [6].
Generation of the atomic models
The atomic models of CCTβ, and CCTδ were generated with the atomic structure of mouse
CCTγ (PDB code 1GML) as template, by homology modelling techniques using the program
Swiss-Pdb Viewer and the SWISS-MODEL server facilities [144]. Hydrophobic surfaces were
visualized with Pymol (DeLano Scientific, San Carlos, CA).
Results
Isolation of the in vivo assembled Gβ1-CCT and PhLP1-Gβ1-CCT complex
The Gβ-CCT and PhLP1-Gβ-CCT complexes are key intermediates in the process of Gβγ
assembly. These complexes were isolated and their structures were determined by cryo-EM in
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an effort to determine the molecular mechanism by which PhLP1 and CCT contribute to the
folding and assembly of the Gβγ dimer. Both complexes were purified from insect cells using an
affinity capture approach. The Gβ1 cDNA was labelled at its C-terminus with an HPC4 tag,
which recognizes a protein C epitope [145], and the PhLP1 cDNA was labelled at its C-terminus
with an His-TEV-myc tag (Fig. 2-1). These constructs were cloned into baculovirus and
expressed in insect Hi5 cells.
An immobilized HPC4
antibody column was used to
purify the Gβ1-CCT
complex, while a tandem
affinity approach using a
Co2+-chelate column and the
HPC4 antibody column was
used to isolate the PhLP1-

Figure 2-2. Characterization of the purified Gβ 1-CCT complex.
(A) Electrophoretic analysis of the purified Gβ1−CCT complex. The
purified Gβ1− CCT complex was run on both a native gel and an SDSPAGE gel. B) The two-dimensional average cryo-image of the immunocomplexes formed by the Gβ 1-CCT complex and the anti-CCTβ 4E217
(1624 particles) monoclonal antibody, respectively.

Gβ1-CCT complex. The
purified products (95 % or higher purity) were analyzed by native and SDS-PAGE
electrophoresis (Fig. 2-2 A & 2-3A), which revealed bands migrating at the correct molecular
weights for CCT subunits, Gβ1 and PhLP1. The presence of all 8 CCT subunits, Gβ1, and PhLP1
in the in vivo assembled complexes was confirmed by immunoblotting and mass spectrometric
analyses (Fig. 2-4). To determine if PhLP1 was phosphorylated at S18-20 in this complex,
PhLP1-Gβ1-CCT was dephosphorylated with alkaline phosphatase and the effect on the mobility
in SDS-PAGE was determined. When PhLP1 is phosphorylated at S18-20 by CK2 its migration
in SDS gels is retarded [114]. Alkaline phosphatase treatment caused a distinct decrease in the
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mobility of the PhLP1 band (Fig. 2-3 A & B), indicating that the PhLP1 in the purified PhLP1Gβ1-CCT complex was indeed phosphorylated at S18-20. These results demonstate that the Gβ1CCT and PhLP1-Gβ1-CCT intermediates in Gβγ assembly could be formed in vivo in insect cells
and isolated to near homogeneity.
The CCTβ subunit is important for the binding of both Gβ1 and PhLP1
Having been able to obtain very pure, in vivo assembled Gβ1-CCT and PhLP1-Gβ1-CCT
complexes, we sought to characterize the nature of the interaction between the chaperonin, Gβ1,
and PhLP1. Aliquots of these complexes were either negatively stained or vitrified and observed
by electron microscopy. For the Gβ1-CCT complex, aliquots of the Gβ1-CCT complex were
independently incubated with monoclonal antibodies that react specifically with CCTβ (4E217)
[123], and several hundred particles were again selected and used to generate the corresponding
two-dimensional average image of the end-on views of the Gβ1-CCT complex bound to these
antibodies (Figure 2-2 B). The two
average images reveal that the
CCTβ subunit was involved in the
interaction with Gβ1, which
indicate that a stable Gβ1-CCT
complex is formed through
specific interactions with the
CCTβ subunit. Similarly, an
immuno-EM of negatively stained
specimens of the purified

Figure 2-3. Characterization of purified PhLP1-Gβ1-CCT
complex.
A) SDS gels of purified PhLP1-Gβ1-CCT complexes in
phosphorylated (left) and dephosphorylated (right) states of
PhLP1. B) Phosphorylation reaction of PhLP1 in the ternary
complex. C) Immunoscopy averaged image of PhLP1-Gβ1-CCT
incubated with monoclonal CCTβ antibodies.
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Figure 2-4. Immunoblotting and mass spectrometry analysis of purified PhLP1-Gβ1-CCT complex.
A) Immunoblots of the purified PhLP1-Gβ1-CCT complex probed with antibodies raised against PhLP1,
Gβ1, CCTα, CCTβ, and CCTζ are shown. B) Mass spectrometry results of the PhLP1-Gβ1-CCT complex
that matched 8 subunits of CCT, human Gβ1 and PhLP1 are shown. Amino acid sequences in red indicate
peptide matches found in the mascot database.
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PhLP1-Gβ1-CCT complex was subsequently performed by incubating the purified ternary
complex with CCTβ monoclonal antibodies to determine which CCT subunit is binding to
PhLP1. A total of 1,968 particles were then selected to generate a two-dimensional average
image of the end-on
views of the PhLP1Gβ1-CCT complex
bound to the CCTβ
antibodies (Figure 2-

Figure 2-5. Projection of Gβ1-CCT structure.
A) 2D Projections of the Gβ1-CCT complex 3D model. B) Actual averaged images
of the Gβ1-CCT complex particles.

3 C). The averaged image revealed the presence of a mass spanning the central folding cavity of
CCT, interacting with 3 subunits in one side of the cavity and 2 subunits in the opposite side of
the CCT complex (Figure 2-3 C). Moreover, the CCTβ subunit was indeed central to the 3
subunits that PhLP1 interacted with in one side of the CCT cavity indicating that PhLP1 also
interacted with the CCTβ subunit.

Three-dimensional structure of the Gβ1-CCT complex
We sought to characterize in more detail the interaction between CCT, Gβ1, and PhLP1 by
cryo-EM of vitrified samples of the Gβ1-CCT and PhLP1-Gβ1-CCT complexes, in the absence of
nucleotide. For the Gβ1-CCT complex, 23,288 particles were selected, and a two-dimensional
maximum-likelihood classification [140] (ML2D) was used to eliminate those particles deviating
from the main population (Figure 2-5 A & B), which included some substrate-free particles
(although the Gβ1-CCT complex was purified using a tag on Gβ1, some particles had lost the Gβ1
molecule). After image classification, 17,521 homogeneous particles were used to generate a 13
Å three-dimensional reconstruction of the Gβ1-CCT complex without imposing any symmetry
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throughout the reconstruction procedure (Figure 2-6 A & B), which revealed the typical doublering structure with one ring showing a more open conformation than the other (Figure 2-6 A &
B). Inside this ring, an almost cylindrical mass was observed facing the apical region of the
chaperonin and interacting mostly with one of the CCT subunits (Figure 2-6 A). This result is
consistent with the two-dimensional analysis showing close proximity of Gβ1 to CCTβ. The
similarity between the shape of the mass inside the chaperonin cavity and the atomic structure of
Gβ1 [68]( pdb 2TRC) prompted us to perform a docking analysis of this structure into the
corresponding mass of the Gβ1-CCT complex (Figure 2-6 C). Docking of the Gβ atomic
structure revealed a good fit when placing the Gβ1 toroidal structure almost parallel to the
longitudinal axis of the apical domain, with one of the β-propeller blades facing the apical
domain of the main Gβ1-interacting CCT subunit. An open β-propeller conformation of Gβ1 was
also docked into the cylindrical mass facing the apical region of the chaperonin, giving an even
better fit (Figure 2-6 D). The α-helix located at the N-terminal region of Gβ1 is left outside the
mass of the reconstructed Gβ1 since this small mass is probably not visualized at the resolution
of this reconstruction. This result suggests that Gβ1 reaches a quasi-native state within the CCT
folding cavity, but does not fold completely into its native state.
A similar docking analysis was carried out by fitting the atomic model of the CCTβ
subunit from the tubulin-CCT crystal structure [1] into the corresponding mass of the CCT
subunit interacting most closely with Gβ1 (Figure 2-6 E & F). The docking shows that the CCTβ
apical domain makes contact with one or two of the Gβ β-propeller blades. Optimal fitting of
Gβ places β-blade 2 (numbered according to [146]) in closest proximity to CCTβ. In support of
this orientation, it has been previously reported that hydrophobic residues from β-strand 3 of
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Figure 2-6. Cryo-EM reconstruction of Gβ1-CCT at 13 Å.
A, B) Side and end-on views of the Gβ1-CCT complex. C, D) Docking native
state (C) or open β-propeller conformation (D) of Gβ 1 atomic structures into
the cryo-EM reconstructed complex. E, F) Side and end-on views of the
docking of the atomic structure of Gβ1 (pdb 2QNS; in red) and the atomic
model of the CCTβ subunit from the tubulin-CCT (purple) crystal structure
[1] into the corresponding masses of the reconstructed Gβ1-CCT complex. G,
H) Close-up of the Gβ1-CCTβ docking. Blue spheres and yellow ribbons
identify residues involved in the proposed binding interaction.
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β-blade 2 contribute to Gβ1 binding to CCT [102]. Furthermore, β-blade 2 specifically pointed
to α-Helix 9 and the loop connecting β-strands 6 and 7 (numbered according to [10]), suggesting
that these regions (shaded blue in Fig. 2-6 E) were involved in the interaction between Gβ1 and
CCTβ (Fig. 2-6 G & H). The first of these two regions has already been suggested to be involved
in substrate recognition [147, 148]), and both regions host a large number of hydrophobic
residues in the CCTβ subunit (Fig. 2-9), which would reinforce the report that Gβ1 interacts with
CCT through a set of defined, hydrophobic residues located in one of the β-strands of its β-blade
2 [102] (Fig. 2-6 G & H).
Determination of Gβ1 binding sites on CCTβ through mutagenesis studies
To test the role of CCTβ and the involvement of the specific regions suggested by the
docking analysis in Gβ1 binding, we performed a mutational analysis of the CCTβ apical
domain. Sequences corresponding to Helix 9 (red in Fig. 2-7A) and the loop between β-strand 6
and 7 (blue in Fig. 2-7A) identified by the cryo-EM analysis as possible Gβ1 binding sites were
replaced with the corresponding sequence of other CCT subunits. Replacement sequences were
chosen to maximize amino acid differences yet minimize structural perturbations. Chimeras of
three additional loops that are more hydrophilic in nature were also made. These loops create a
hydrophilic surface previously proposed to line the interior of the CCT folding cavity and bind
substrates [10]. These chimeras included the loop preceding the helical protrusion (Chim 242,
green in Fig. 2-7A), the loop between α-Helix 9 and β-strand 9 (Chim 293, purple in Fig. 2-7A)
and the region encompassed by β-strand 10 and the loop between this strand and α-Helix 10
(Chim 311, orange in Fig. 2-7A). As a control, a chimera was also made of the loop after αHelix 10 at the back of the apical domain, facing the exterior of the chaperonin, which would not
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Figure 2-7. Gβ1 and α-tubulin bind a hydrophobic face of CCTβ.
HEK 293T cells were transfected with HA-tagged CCTβ or δ chimeras and
FLAG-tagged Gβ1, α-tubulin, or VHL. CCT-substrate complexes were
immunoprecipitated with anti-HA antibody, and substrate binding to CCT was
measured by Western blotting. A) Design of CCT chimeras. Regions of CCTβ
and δ were replaced with corresponding amino acids of other CCT subunits, as
indicated in the table. Chimeric regions are mapped on the CCTγ apical domain
(1GML), using UCSF Chimera [4]. Chim 322 serves as a control, as its chimeric
amino acids are on the exterior of the CCT cavity. B) Gβ1 binding to CCTβ
chimeras. C) Gβ1 binding to CCTδ chimeras. CCTδ is across from CCTβ in the
folding cavity. D) α-tubulin binding to CCTβ chimeras. E) VHL binding to
CCTβ chimeras. Data represent the average ± SEM of at least three experiments;
* p < 0.05 and ** p < 0.01, both as compared to WT. Data from Panels A, B, D,
E were provided by Rebecca Plimpton.
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be expected to
interfere with Gβ1
binding (Chim 322,
yellow in Fig. 2-7A).
The Gβ1 binding
activity of these
chimeras was tested
by transfecting
HEK-293T cells
with Gβ1 and HA-

Figure 2-8. Incorporation analysis of CCTβ and CCTδ variants.
CCTβ and δ variants incorporate into endogenous CCT complexes. HEK 293T
cells were transfected with HA-tagged CCTβ or δ. CCT complexes were
immunoprecipitated with anti-HA antibody, and incorporation was measured by
Western blotting. A) Incorporation of CCTβ chimeras. B) Incorporation analysis
of CCTδ chimeras. Data represent the average ± SEM of at least three
experiments. Data from Panel A were provided by Rebecca Plimpton.

tagged versions of the chimeric CCTβ constructs or wild-type CCTβ, immunoprecipitating with
an antibody to the HA tag and immunoblotting for Gβ1 to quantify the amount of Gβ1 bound to
CCTβ. This method ensures that only the Gβ1 bound to the HA-tagged chimeric subunits was
measured. The results show a significant reduction in Gβ1 binding only in chimeras 224 and
299, the two regions suggested by the docking analysis to be involved in Gβ1 interaction (Fig. 27B).
To determine if this reduction in Gβ1 binding was specific to the CCTβ subunit, three
chimeras were made to corresponding regions in CCTδ, which sits on the opposite side of the
CCT toroid as CCTβ [149]. These chimeras corresponded to the two CCTβ chimeras with
reduced Gβ1 binding (CCTδ chimeras 233 = CCTβ chimera 224; and 312 = CCTβ chimera 299)
and one additional chimera with normal Gβ1 binding (CCTδ chimera 251). None of these
chimeras showed a change in Gβ1 binding, indicating that Gβ1 does not interact with these
regions of CCTδ (Fig. 2-7C).
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Additional binding experiments were performed to determine if other CCT substrates
interacted with these regions of the CCTβ apical domain. The binding of α-tubulin and VHL to
the CCTβ chimeras was determined by co-immunoprecipitation as described for Gβ1. For αtubulin, Chim 299 showed a significant reduction in binding while the other chimeras bound
similarly to wild-type CCTβ. This result is consistent with previous reports pointing to an
interaction of tubulin with CCTβ [1, 136]. For VHL, there was no significant difference in
binding between the wild-type CCTβ and any of the chimeras, suggesting that VHL does not
interact with the apical domain of CCTβ. This result is also consistent with previous reports that
VHL interacts with CCTα and CCTη [147]. In addition, these results show that the chimeric
CCTβ subunits were properly folded and capable of binding substrates.
This conclusion was confirmed by measuring the incorporation of the CCTβ and δ chimeras
into CCT complexes. All of the chimeras showed at least 50% incorporation compared to wildtype CCTβ, and there was no correlation between the extent of substrate binding and the degree
of incorporation, indicating that reduced binding of Gβ1 to the CCTβ 224 and 299 chimeras was
not caused by an inability of these chimeras to fold and form viable CCT complexes (Fig. 2-8).
Together, the chimera binding data demonstrate a direct interaction of Gβ1 with Helix 9 and loop
between β-strand 6 and 7 of the CCTβ apical domain. In addition, the Helix 9 interaction site
appears to be shared with α-tubulin. These findings support a structural model that places this
face of the CCT apical domains facing the chaperonin cavity in the open confirmation of CCT
[150].

Moreover, these results are consistent with previous studies showing specificity in

substrate binding to CCT subunits.
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It has been reported that Gβ1
interacts with CCT through a series of
hydrophobic residues from β-propeller
blade

2

suggests

[102].
an

This

observation

interaction

with

hydrophobic residues in the 224-228
and

299-309

regions

of

CCTβ.

Indeed, the hydrophobic profile of
these two regions reinforces this
notion (Fig. 2-9; Figure 2-10 A). In
particular, the 299-309 region has
hydrophobic residues covering not

Figure 2-9. Hydrophobic regions of the apical domains of
CCTβ and CCTδ.
Hydrophobic surface models of the apical domains of CCTβ
and CCTδ (a non Gβ1-interacting subunit) are shown.
Hydrophobic residues are colored yellow. Black ellipsoids
indicate the groove between α-helices 8 and 9 and arrows
point to the α-Helix 9 and loop between β-strands 6 and 7
regions (left and right, respectively). Structures were
generated by modeling the human sequences against the
mouse CCTγ apical domain using SWISS-MODEL [8].

only most of α-Helix 9 but also the cleft between this helix and α-Helix 8 (the helical protrusion)
(circled in Fig. 2-9). Furthermore, this hydrophobic cleft is not conserved in CCTδ (Fig. 2-9),
which is not involved in Gβ1 binding (Fig. 2-7C). Additional support for the importance of the
hydrophobic cleft of CCTβ in substrate binding comes from the fact that α-tubulin also interacts
with this region and that a highly hydrophobic sequence of β-tubulin, which is conserved in αtubulin, contributes significantly to CCT binding [151, 152].
Three-dimensional structure of the PhLP1-Gβ 1-CCT complex
To better understand the role of PhLP1 in Gβ folding and assembly with Gγ, the PhLP1Gβ1-CCT complex was also isolated from insect cells and the cryo-EM structure of the complex
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Figure 2-10. CCT sequence alignments.
A) Alignment of the eight Homo sapiens CCT subunits. B) Alignment of eukaryotic CCTβ subunits.
Alignments were performed using ClustalX2, version 2.0.12 [6]. Colors indicate the chemical nature of the
amino acid: nonpolar (black), polar (green), negatively charged (red), or positively charged (blue).
Secondary structure was assigned from the crystal structure of the CCTγ apical domain (1GML), using
UCSF Chimera [4]. Secondary structure elements are numbered as in Pappenberger et al.[10]. Chimeric
regions designed for CCT substrate binding experiments are boxed.
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Figure 2-11. Cryo-EM reconstruction of PhLP1-Gβ1-CCT at 18 Å.
A, B) Side and end-on views of the PhLP1-Gβ1-CCT complex. C, D) Docking of the
Pdc-Gβ 1 atomic structures into the cryo-EM reconstructed complex. E, F) Side and
end-on views of the docking of the atomic structure of Pdc-Gβ1 (pdb 2QNS; in red) and
the atomic model of a CCT subunit from the tubulin-CCT crystal structure (pdb 2XSM;
in magenta, dark green, purple, dark yellow and blue) into the corresponding masses of
the reconstructed PhLP1-Gβ1-CCT complex.
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was determined. The cryo-EM analysis revealed some heterogeneity in the PhLP1-Gβ1-CCT
sample with several sub-populations that could be classified into CCT alone, Gβ1-CCT and
PhLP1-Gβ1-CCT complexes, suggesting that the PhLP1-Gβ1-CCT complex is somewhat
unstable. This instability is consistent with the observation that PhLP1 enhances the release of
Gβ1 from CCT [114]. After sorting the complexes, a total of 11,634 homogeneous PhLP1-Gβ1CCT particles were used to generate a ~18 Å three-dimensional reconstruction of the complex
without imposing any symmetry throughout the reconstruction procedure (Figure 2-11 A & B).
The structure resembles that of the PhLP1-CCT complex [105] with a mass spanning the CCT
folding cavity, interacting with three subunits on one side of the cavity and two on the opposite
side. There is an additional mass deep within the folding cavity that was not seen in the PhLP1CCT structure. Docking of the Pdc- Gβ1 atomic structure [3] into the cryo-EM structure gives a
good fit with Gβ1 oriented in the mass inside the folding cavity and Pdc oriented above Gβ1 in
the mass spanning the cavity (Figure 2-11 C & D). In this structure, it is very likely that Gβ1
retains its binding contacts with CCTβ. If so, the docking places the N-terminal, Gβ-binding
domain of PhLP1 in close proximity to CCTβ, γ and ζ on one side of the cavity and the Cterminal domain of PhLP1 in close proximity to CCTδ and η on the opposite side of the cavity.
This same orientation of PhLP1 was observed in the PhLP1-CCT structure [105]. Additional
docking of the atomic structure of these CCT subunits [1] into the cryo-EM structure gives a
good fit with CCTβ coming into close contact with Gβ1 and the N-terminal domain of PhLP1
(Fig. 2-11 E&F).
There are some important differences in the position of Gβ1 and PhLP1 in the PhLP1- Gβ1CCT complex compared to the Gβ1-CCT and PhLP1-CCT complexes. First, in the Gβ1-CCT
reconstruction, the Gβ1 electron density is larger than the native Gβ1 β-propeller in the absence
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of PhLP1 (Figure 2-6 D),
suggesting a more open form of
the β-propeller. In the presence
of PhLP1, the Gβ1 β-propeller is
more narrow (Fig. 2-12 A-B),
implying that PhLP1 binding
constricts the β-propeller into a
more native conformation.
Second, the position of Gβ on
CCT is shifted to the left in the
presence of PhLP1, indicating a
change in binding contacts
between Gβ1 and CCTβ upon
PhLP1 binding (Fig. 2-12 A-B).
This change in binding contacts

Figure 2-12. A proposed mechanism of PhLP1-mediated Gβ1
folding and release from CCT.
A, B) Shows the comparison of Gβ1 positions before (red) and after
(green) PhLP1 binding. PhLP1 binding shifts the position of the
folded Gβ1 by ~10 Å. This shift results in a change in contacts
between Gβ1 and CCTβ, which is most likely responsible for the
release of PhLP1-Gβ 1 from the CCT complex C) Differences in the
position of PhLP1 in the PhLP1-Gβ1-CCT complex (left) compared
to the PhLP1-CCT complex (right) suggest that PhLP1 sits down
deeper into the folding cavity of CCT to reach Gβ1. This
reorientation of PhLP1 allows PhLP1 to bind Gβ1 while maintaining
contacts with CCT subunits in both sides of the folding cavity.

may be responsible for the release of Gβ from CCT upon PhLP1 binding. Third, PhLP1 sits
much lower on CCT, more into the folding cavity in the presence of Gβ1. This reorientation of
PhLP1 is likely a result of the binding of PhLP1 to Gβ1 in the folding cavity.

Mutagenesis studies reveal a binding site for PhLP1 on CCTβ
The docking analysis of PhLP1-Gβ1-CCT points to an interaction between PhLP1 and
CCTβ in addition to the interaction of Gβ1 with CCTβ. One would predict that the residues of
CCTβ involved in an interaction with PhLP1 would lie above those residues of CCTβ involved
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in Gβ1 binding since PhLP1
sits above Gβ1 in the CCT
folding cavity. The only
*

region of the CCTβ apical
domain that sits above the
Helix 9 Gβ1 binding site is
the helical extension of
Helix 8 (Fig. 2-7A).
Therefore, we substituted
residues in the helical
extension and measured their

Figure 2-13. PhLP1 binding to CCTβ S260 mutants.
A) S260 residue is located at the tip of CCTβ apical domain. B) PhLP1CCTβ S260A/D binding data. C) Incorporation data of CCTβ S260A/D
variants. PhLP1 interacts with a serine in the CCTβ helical protrusion.
HEK 293T cells were transfected with HA-tagged CCTβ S260 variants and
Myc-tagged PhLP1. PhLP1-CCT complexes were immunoprecipitated
with anti-HA antibody, and binding was measured by Western blotting.
The S260 residue is indicated (blue) in the apical domain of the CCTβ
structure (3KTT), using UCSF Chimera [4]. Incorporation of CCTβ S260
variants are shown in C). Data represent the average ± SEM of at least
three experiments; * p < 0.05, as compared to WT.

effect on PhLP1 binding to
CCTβ. Unexpectedly, many amino acid substitutions in the helical extension yielded variants
with very poor incorporation into the CCT complex (data not shown), with the exception of S260
substitutions. The S260 site on CCTβ sits at the very top of the helical extension (Fig. 2-13) and
has previously been shown to be phosphorylated by the p90 ribosomal S6 kinase (RSK) and the
p70 ribosomal S6 kinase (S6K) that are activated by the extracellular signal-regulated kinase
(ERK) and mammalian target of rapamycin (mTOR) signalling pathways [153]. These signaling
pathways can regulate a range of cellular responses including cell proliferation and growth [154].
An S260A substitution had no effect on PhLP1 binding to CCTβ, but a phosphorylationmimicking S260D substitution reduced PhLP1 binding to CCTβ by approximately 50% (Figure
2-13 B). Both of these variants showed normal incorporation into CCT complexes (Fig. 2-13 C),
indicating that they were folding normally and that the decreased binding of PhLP1 to the S260D
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variant was most likely the result of direct disruption of an interaction of PhLP1 with CCTβ.
From this result, two important observations can be made. First, an important PhLP1-CCT
interaction site is found near the tip of the CCTβ helical extension, supporting the docking
analysis that pointed to an interaction of the N-terminal domain of PhLP1 with CCTβ. Second,
PhLP1 binding to CCT and thus Gβγ assembly may be regulated by RSK and S6K
phosphorylation.
Discussion
CCT can fold single monomers of an oligomeric complex and maintain their assembly
competent state until the oligomeric complex assembly occurs [81]. Therefore, some of these
substrates are only released from CCT in the presence of their binding partners [101, 155, 156].
In this way, CCT can serve as a reservoir for their stabilization against aggregation or
degradation until complex assembly takes place [100]. This may be the case for the assembly
process of the heterotrimeric G protein αβγ complex, which is important for the propagation of
GPCR signaling. The CCT-assisted assembly of Gβ and Gγ into the Gβγ dimer is particularly
challenging. Nascent polypeptides of Gβ and Gγ emerging from a translating ribosome face a
propensity to aggregate since neither of these subunits is stable on its own. Moreover, the folding
process of Gβ is complicated because it must bring together regions that are far removed from
each other in the primary sequence to form the β-propeller structure. As a result, Gβ folding
requires CCT and an essential co-chaperone, PhLP1, which catalyzes Gβγ assembly by binding
to Gβ in the CCT folding cavity and releasing Gβ from CCT [114]. To better understand the
mechanism of this assembly process, we have characterized two important intermediates, Gβ1CCT and PhLP1-Gβ1-CCT complexes, through cryo-electron microscopy analysis and site51

directed mutagenesis. These complexes are unique in that they were isolated directly from cells.
As such, the Gβ1-CCT and PhLP1-Gβ1-CCT structures should be good representations of the
complexes as they exist in vivo.

Binding of Gβ1 to CCT
The immuno-microscopy and cryo-EM analysis of the Gβ1-CCT complex reveals that Gβ1
interacts specifically with CCTβ in the folding cavity (Fig. 2-2 B; Fig. 2-6 E & F). Docking
analysis of the Gβ1-CCT structure suggests that Gβ1 has achieved a quasi-folded state with an
open β-propeller structure while bound to CCT (Fig. 2-6 C & D). Moreover, optimal docking
indicates that β-propeller blade 2 of Gβ1 specifically points to α-Helix 9 and the loop between βstrands 6 and 7 of the CCTβ apical domain (Fig 2-6 E-H). Both of these regions of the CCTβ
apical domain face the interior of the chaperonin cavity [150] and together form a hydrophobic
face (Fig. 2-9). In the atomic model, these regions of CCT are 3.4 Å apart and they are in close
proximity to the β-blade 2 of Gβ1, the Gβ1 blade containing the amino acids proposed to be
involved in CCT binding [102]. This proposed interaction was confirmed by the mutagenesis
results which showed that chimeras of these regions of CCTβ had significantly reduced Gβ1
binding (Fig. 2-7 C). Since there is considerably more hydrophobicity of these regions in CCTβ
compared to the same region of any other CCT subunits (Fig. 2-9; 2-10 A), it seems likely that
Gβ1 interacts with these regions of the apical domain of CCTβ through a set of defined,
hydrophobic residues located in one of the β-strands of β-blade 2 (Fig. 2-6 G-H).
One of the β-strands in VHL interacts specifically with the hydrophobic residues of Helix 9 of
CCTα [147]. The general hydrophobicity of Helix 9 is conserved in both CCTα and β but the
positions of charged and hydrophilic residues are not (Fig. 2-10 A). Thus, the binding specificity
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of Gβ1 and VHL appears to come from the specific structural environment of the CCT apical
domains in the region surrounding Helix 9. Interestingly, the analogous region of GroEL is also
responsible for binding its substrates [148, 157]. These observations suggest that many CCT
substrates with β-sheet structures might bind in the Helix 9 region and that the amino acid
sequence diversity of the CCT apical domains in this region provides the specificity of substrate
recognition. This is in contrast to the non-specific hydrophobic interactions described for GroEL
and its substrates [157-159].
Role of PhLP1 in the folding and release of Gβ from CCT
As described earlier, CCT is a more complex chaperonin than the rest of the family and uses
a plethora of co-factors or co-chaperones in folding its substrates [106, 123]. CCT-assisted
folding and release of Gβ proteins require interaction with PhLP1 [57, 73, 114], and we have
used cryo-EM analysis to determine the PhLP1-Gβ1-CCT structure, in which the PhLP1 is in its
phosphorylated state (Figure 2-11 A-B). Several important insights regarding the mechanistic
details of the PhLP1-mediated Gβγ assembly process can be drawn from the structural analysis
of this complex. First, the cryo-EM analysis suggests that the N-terminal domain of PhLP1 binds
above Gβ1 in the folding cavity simultaneously contacting the CCTβ, γ and ζ on one side of the
cavity, while the C-terminal domain of PhLP1 interacts with CCTδ and η on the opposite side of
the cavity (Fig. 2-3 C; Fig. 2-11 E & F). Moreover, the docking analysis indicates that Gβ1
retains binding contacts with CCTβ while binding to PhLP1 (Fig. 2-11 E & F). Second,
differences in the position of PhLP1 in the PhLP1-Gβ1-CCT complex compared to the PhLP1CCT complex suggest that PhLP1 sits down deeper into the folding cavity of CCT to reach Gβ1
(Fig. 2-12 C). This reorientation of PhLP1 allows PhLP1 to bind Gβ1 while maintaining contacts
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with CCT subunits in both sides of the folding cavity (Fig. 2-12 C). Third, a comparison between
the electron densities of Gβ1 in the Gβ1-CCT and PhLP1- Gβ1-CCT structures reveals that in the
presence of PhLP1, the Gβ1 β-propeller is more narrow (Fig. 2-12 A & B), implying that PhLP1
binding constricts the Gβ1 β-propeller strands, probably completing its folding and stabilizing the
native conformation of Gβ1. Fourth, PhLP1 binding shifts the position of the folded Gβ1 by ~10
Å. This shift must result in a change in contacts between Gβ1 and CCTβ, which is most likely
responsible for the release of PhLP1-Gβ1 from the CCT complex (Fig. 2-12 A & B). Finally, the
stability of the Gβ1-CCT complex shows that Gβ1 cannot be released by the normal ATP binding
and hydrolysis cycle of CCT. Moreover, the structure of the PhLP1- Gβ1-CCT complex
indicates that it is very unlikely that PhLP1 can remain bound in the closed, ATP-hydrolysis
transition state of CCT. Therefore, it appears that PhLP1 binds Gβ1-CCT in the open form and
releases PhLP1-Gβ1 prior to ATP binding and hydrolysis.
The heterogeneity of the PhLP1- Gβ1-CCT complex reflects its relative instability
compared to the Gβ1-CCT complex. In fact, our ability to purify the complex was greatly
enhanced by the absence of over-expressed Gγ in our insect cell expression system. In the
presence of Gγ, Gβ release from CCT is accelerated, not because Gγ binds Gβ in the CCT
folding cavity, but most likely because Gβ assembly with Gγ drives the equilibrium toward the
dissociation of the PhLP1-Gβ1-CCT complex by irreversible formation of the Gβγ dimer. In this
manner, the stable Gβγ complex is brought together from its unstable subunits for subsequent
association with the Gα subunit to form a heterotrimer and release PhLP1 to participate in
subsequent rounds of Gβγ dimerization.
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PhLP1 binds CCT at the tip of the helical protrusion
Docking of the Pdc-Gβ1γ1 atomic structure [3] onto the PhLP1-Gβ1-CCT structure places a
region of Pdc corresponding to an important CCT binding site of PhLP1 in contact with CCTβ
(Fig. 2-11 E & F). Our mutagenesis data has provided evidence that PhLP1 can interact with
residue S260 of CCTβ, which is located at the tip of the helical protrusion of the apical domain
[150, 160] (Figure 2-13 A). Interestingly, both RSK of the ERK signalling pathway and S6K
from the PI3K-mTOR signalling pathway can phosphorylate CCTβ subunit at this residue [153].
Based on the fact that the phosphorylation mimicking S260D substitution decreases the binding
of PhLP1 to CCT, and that S260 is phosphorylated by RSK and S6K, it is possible that the Gβγ
assembly may be regulated by the ERK and mTOR pathways. Since phosphorylation by CK2 at
S18-20 in N-terminus of PhLP1 can enhance the release of Gβ from CCT, it also seems possible
that these phosphorylation events on PhLP1 and CCTβ can work in concert to enhance the
release of Gβ1 from CCT due to their mutual electrostatic repulsion. In this way, Gβγ assembly
may be regulated by signals that activate the ERK or mTOR pathways. This is an intriguing
possibility that merits further investigation.
In conclusion, we have analyzed the process of PhLP1-mediated Gβγ assembly and
determined using cryo-electron microscopy the first structures of two in vivo assembled
intermediates in this process, Gβ1-CCT and PhLP1-Gβ1-CCT. This study shows the exquisite
way in which CCT and PhLP1 work together to fold and assemble Gβγ, and it also suggests
possible novel ways of regulating Gβγ assembly.
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CHAPTER 3:
ROD-SPECIFIC PHOSDUCIN-LIKE PROTEIN 1 (PHLP1) CONDITIONAL KNOCKOUT
MICE REVEAL THE ROLE OF PHLP1 FOR Gβγ SUBUNIT ASSEMBLY IN VIVO
Summary
G proteins play a vital role in cellular signal transduction processes [15, 21, 22]. Our lab and
others have recently shown that the nascent Gβ polypeptide requires the assistance of the
cytosolic chaperonin complex (CCT) to fold correctly into its native tertiary structure [113, 114].
Folding of Gβ also requires a co-chaperone, phosducin-like protein 1 (PhLP1), which interacts
with the CCT apical domains to form a PhLP1-Gβ-CCT ternary complex that subsequently
breaks down and releases PhLP1-Gβ from CCT for association with Gγ and formation of the
Gβγ dimer [73, 114]. This mechanism of PhLP1-mediated Gβγ assembly is derived from cell
culture experiments and structural data, but has yet to be tested in vivo. Here we report the first in
vivo study of PhLP1 function from a retinal rod photoreceptor-specific PhLP1 conditional
knockout mouse. This mouse provides a model in which the physiological consequences of the
loss of PhLP1 function can be characterized in the G protein signaling system of mammalian
vision. In this mouse, all G protein subunits that express in the rod photoreceptor cells were
significantly down-regulated, resulting in severely impaired photoresponses. Moreover,
significant down-regulation of Gβ5 and RGS9-1 was also observed, indicating that PhLP1 plays
as important role in Gβ5-RGS dimer formation as it does in the Gβγ assembly process. These
findings demonstrate that PhLP1 is required for the folding and assembly of Gβγ in vivo and
extend this essential role of PhLP1 to Gβ5-RGS9 dimers as well.
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Introduction
G protein signaling is essential for regulating a large variety of physiological processes
such as cardiac rhythm and output, neuronal signaling, immune responses and sensory detection
[15, 21, 22]; and the malfunctioning of these signaling processes can lead to devastating diseases
such as cancer, heart disease, vision impairment, neural diseases, and hypertension [16-20].
Many different ligands such as small molecule neurotransmitters, peptide hormones,
chemokines, lipids, odorants and even photons of light can trigger the activation of GPCR
signaling, which is is particularly important in the phototransduction cascade. The light-activated
GPCR rhodopsin associates with the heterotrimeric G protein transducin αβγ subunits (Gt) and
catalyzes the exchange of GDP to GTP on the transducin α subunit (Gαt). As Gαt-GTP
dissociates from the activated receptor and Gtβγ dimers, it interacts with the cGMP
phosphodiesterase (PDE) and activates the cGMP hydrolysis activity of PDE. The rapidly
decreased cytoplasmic cGMP concentration results in the closure of cGMP-gated cation channels
in the plasma membrane of the photoreceptor outer segment and hyperpolarizes the membrane
potential to signal a light response. The RGS9-1/Gβ5-L/R9AP GAP complex accelerates the
hydrolysis of GTP in Gαt to GDP resulting in the dissociation of Gαt-GDP from PDE and the G
protein cycle terminates. The Gαβγ complex is then reformed by the association between GαtGDP and Gβγ subunits [16].
To perform these essential functions, the G protein heterotrimer must be assembled from its
nascent α, β and γ polypeptides. This is no small task given the fact that Gβ and Gγ are unstable
proteins on their own, but must associate and form the Gβγ dimer to achieve a stable quarternary
structure. Our lab and others have recently shown that the nascent Gβ polypeptide requires the
assistance of the cytosolic chaperonin complex (CCT) to fold correctly into its native tertiary
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structure [113, 114]. Folding of Gβ also requires a co-chaperone, phosducin-like protein 1
(PhLP1), which interacts with the CCT apical domains to form a PhLP1-Gβ-CCT ternary
complex that is an important intermediate in Gβγ assembly [73, 114]. If PhLP1 is
phosphorylated in this complex, it triggers the release of Gβ from CCT in what is believed to be
a phospho-PhLP1-Gβ dimer that can then interact with the Gγ subunit to form the Gβγ dimer
[114].
The mechanism of PhLP1-mediated Gβγ assembly has been studied extensively in cell culture
experiments and structural studies. The next important step in testing this hypothesis is to
investigate the function of PhLP1 in vivo. A previous study has revealed the dominant effect of
PhLP1 by using transgenic expression of the PhLP1 ∆1-83 mutant in the mouse rod
photoreceptor cells [161]. Since PhLP1 binds the Gβ subunit with its N-terminal domain,
deletion of PhLP1 N-terminal domain resulted in impaired Gβ subunit folding. Moreover, the
over-expressed PhLP1 ∆1-83 mutant formed a stable complex with trapped Gβ and CCT in the
rod photoreceptor cells, leading to the unavailability of CCT to other protein substrates.
Although the expression of G protein transducin β and γ subunits were essentially eliminated in
this study, supporting the current thesis that PhLP1 is important for Gβγ assembly, a large
disturbance of cellular functions in the rod photoreceptor cells resulted due to the impaired
functions of CCT. Since the loss of many other important visual proteins such as rhodopsin and
PDEαβ may not be a direct result from the loss of PhLP1 function, it was difficult to interpret
the actual physiological roles of PhLP1. As a result, it is imperative to make an actual knockout
of PhLP in order to assess the physiological functions of PhLP1 in vivo. However, it is important
to do a conditional knockout instead of a whole animal knockout because if PhLP1 is required
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for Gβγ assembly, then a whole animal knockout would be expected to be embryonically lethal.
This prediction stems from the fact that the Gβ knockout is embryonically lethal [162].
The Cre-Lox recombination system has been widely used for the development of conditional
knockout mice by initiating site-specific recombination in genomic DNA [163]. Cre recombinase
is able to catalyze the recombination of DNA between two loxP sequences. When cells that have
loxP sites in their genome express Cre, a recombination event will occur between the loxP sites
so that the double-stranded DNA between the loxP sites is excised and the surrounding DNA is
ligated back together by the Cre protein. Therefore, expression of Cre recombinase under the
control of a tissue-specific promoter can facilitate the cleavage of any genes flanked by two
LoxP sequences oriented in the same direction in a tissue-specific manner.
Therefore, we used the Cre-LoxP system to conditionally knockout the PhLP1 gene in the
photoreceptor cells of the retina to determine the effects of PhLP1 deletion on Gβγ expression
and G protein signaling. Photoreceptor cells are an ideal model system for these experiments
because the process by which they convert light into a neuronal response (called
phototransduction) is a well-studied G protein-dependent pathway [15]. We have prepared genetargeted mice in which the PhLP1 gene was flanked by two loxP sites. We subsequently crossed
these mice with iCre75 mice in which the Cre recombinase is expressed only in retinal rod
photoreceptor cells under the control of the rhodopsin promoter. The resulting mice lack PhLP1
only in their rod photoreceptors. The loss of PhLP1 led to profound consequences on the ability
of these rods to detect light as a result of a significant reduction in the expression of transducin
(Gt) subunits. Expression of other G protein subunits as well as Gβ5-RGS9-1 complexes was also
greatly decreased, yet all of this occurs without causing rapid degeneration of the photoreceptor
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cells. These results show for the first time the essential nature of PhLP1 for Gβγ and Gβ5-RGS
dimer assembly in vivo, confirming and extending results from cell culture and structural studies.
Experimental Procedures
Development of PhLP1-LoxP targeting vector
The development and construction of PhLP1-LoxP targeting vector were performed based on
a previously described protocol [164]. The detailed experimental procedures are described here.
Preparation of Red-competent BAC containing E. coli
E. coli containing the PhLP1 BAC clones (BACPAC Resource Center; Cat: RP23-464H12)
were inoculated into 5 mL of SOB, 20 mg ml–1 chloramphenicol, and grown at 30–32°C
overnight. The cells were made electro-compotent using the following protocol. Cells were by
centrifuged at 2000 g for 5 min at 4°C. The supernatant was discarded, the cells were
resuspended in 1 ml of 10% ice cold glycerol, transferred into a 1.7-ml Eppendorf tube and
centrifuged at 8,000g at 4°C in a microcentrifuge for 10 s. The supernatant was discarded, the
cells were resuspended again in 1 mL of 10% (vol/vol) ice cold glycerol and centrifuged again as
before. The supernatant was again discarded, the cells were resuspended in 100 µl of 10%
(vol/vol) ice cold glycerol and divided into two 50-ul aliquots. A total of 10 ng of the Red
recombinase-expressing plasmid pKD46 was transformed to one tube of the freshly made
electro-competent cells by electroporation under the default setting. A total of 300 µL of SOC
medium was added immediately after the pulse, and the cells were transferred into an Eppendorf
tube. Without additional incubation, 50 µl of the cells were spread onto LB-agar plates
containing 100 mg ml–1 ampicillin and 20 mg ml–1 chloramphenicol. The plates were then
incubated at 30–32°C for 24–30 hrs. After incubation, a single colony was picked and grown in a
15-ml tube containing 5 ml of SOB medium containing ampicillin and chloramphenicol and was
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incubated at 30–32°C overnight. An appropriate amount of the culture was inoculated into a 250mL ﬂask containing 50 ml of SOB medium containing ampicillin and chloramphenicol to reach a
ﬁnal OD600 of about 0.1–0.2. To induce the expression of the Red recombinase, L-arabinose
(powder or freshly made liquid stock) was added to a ﬁnal concentration of 0.1%, and the
bacterial culture was incubated at 30–32°C. When the OD600 was between 0.4–0.8, the culture
was transferred into a 50-mL conical tube and left on ice for 10 min with occasional swirling.
The cells were centrifuged for 15 min at 2,000g at 4°C, and the supernatant was discarded. The
cells were resuspended gently in 50 mL of ice cold 10% glycerol and centrifuged as before. The
supernatant was again discarded, and the cells were resuspended gently in 25 mL of ice cold
10% glycerol and were centrifuged as before. After the centrifugation, the supernatant was
discarded, and the cells were resuspended gently in 25 mL of ice cold 10% glycerol and
centrifuged as before. Finally, the supernatant was discarded and any remaining liquid was
removed by pipetting. Approximately 100 µl of fresh ice cold 10% (vol/vol) glycerol was added
and the pellet was resuspended. The cells were then divided into 50-100 µl aliquots. These
aliquots were either used immediately or stored at -80°C for later use.
Preparation of chemically competent DH5α cells
DH5α E. coli were inoculated onto an LB-agar plate and incubated at 37°C overnight. A
single colony was picked and grown in 5 ml SOB medium at 37°C overnight. After determining
the OD600, 1 ml was transferred into 250 ml of SOB medium in a 2-L ﬂask to obtain OD600 of
approximately 0.01–0.02. The cell culture was incubated at 21–24°C with shaking (200–300
rpm). When the OD600 of the cells reached approximately 0.5–0.6, the culture was transferred
into a large centrifuge tube and left on ice for 10–20 min with occasional shaking. The cells were
centrifuged at 2,500g at 4°C for 10 min. The cell pellet was gently resuspended in 80 ml of ice
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cold 10% glycerol and was left on ice for 10 min. The cells were again centrifuged as before.
The pellet was then resuspended gently in 20 ml of ice cold 10% glycerol. A total of 1.4 ml of
DMSO was added to the tube and mixed well, and the tube was kept on ice for 10 min. The
competent cells were divided into 50 µl aliquots and frozen in liquid nitrogen and were stored at
80 °C until used.
Preparation of Red-competent DH5α/pKD46 cells
A total of 50 µl of chemically competent DH5α cells were transformed with pKD46 (~10 ng)
by 42°C heat shock for 1 min. Right after heat shock, the transformed cells were directly spread
onto an LB-agar plate with 100 mg ml–1 ampicillin and grown at 30–32°C for ~24 to 30 hrs.
Several colonies were picked and grown in 20 ml of SOB medium overnight at 30–32°C. After
determining the OD600, appropriately 10 ml of culture were inoculated into a 1-L ﬂask containing
250 ml of SOB medium to reach an OD600 of ~0.1–0.2. A total of 0.25 g (0.1%) L-arabinose
powder was added to the culture, and the culture was incubated at 30–32°C with shaking (200–
300 rpm) for another 2 to 4 hrs. When the OD600 of the cells reaches ~0.4–0.8, the culture was
transferred into a large centrifuge tube and was left on ice for 10–20 min with occasional
shaking. The cells were centrifuged for 5 min at 4,000g at 4°C. The supernatant was discarded,
and the pellets were resuspended gently in 200 ml of ice cold 10% (vol/vol) glycerol. The cells
were again centrifuged as above and the supernatant was discarded. The pellets were gently
resuspended in 200 ml of ice cold 10% (vol/vol) glycerol and centrifuged again as above. The
supernatant was again discarded, and the pellet was resuspended gently in 100 ml of ice cold
10% (vol/vol) glycerol. The cells were centrifuged again as before and the supernatant was
discarded. The pellet was gently resuspended in a fresh 0.5 ml of ice cold 10% (vol/vol) glycerol.
The cells were then divided into 50 µl aliquots and snap frozen in liquid nitrogen.
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Subcloning of the PhLP1 genomic fragment into the pStart-K vector
Two oligonucleotides were designed for PCR amplification of the pStartK vector for
construction of the targeting vector with the PhLP1 gene. The upstream oligo sequence was:
TGAAGTGCTTATTACTTTAATAGTTTCAAAGTCATGGATCTATTTGATGAgccgcactcgag
atatctagaccca; and the downstream oligo sequence was: AGGCAAGAGCTGGAGTGGAGA
AAAACTCAAATGGGACCTGGGGCTTTTCCcgactgaattggttcctttaaagc. Sequences in capital
letters share 50-bp homologous sequences with the targeting regions of the BAC plasmid.
Sequences in lowercase anneal to the backbone of pStartK. These two primers were used to
amplify the template pStartK by PCR (5 x 25-µl reactions: pStart-K, 50 ng; 10x buffer, 12.5 µl;
25 mM MgCl2, 10 µl; primers, 2.5 µl each at 10 mM; 10 mM dNTP, 2.5 µl; Pfx Taq, 1.25 µl;
H2O was added to a total volume of 125 µl; PCR conditions: 94°C 2 min; 30 cycles of 94°C 30 s,
59°C 30 s and 68°C 90 s; 68°C 7 min.). The amplified PCR products were combined and
purified using a QIAprep PCR purification column following the manufacturer’s instructions and
eluted with 100 µl H2O. The eluted DNA was digested with 2 µl (20 U) of DpnI for 1–2 h at
37°C. The reaction was re-purified on a QIAprep column and eluted with 40 µl H2O. The
purified PCR product (5-10 µl) was electroporated into 50 µl of the Red-competent E. coli
previously transformed with the targeting BAC plasmid. One ml of SOC medium was used for
rescue immediately after the pulse, and the cells were transferred into a 1.7-ml Eppendorf tube
and incubated at 37°C for 1 h. The cells were plated onto LB-agar plates with 50 µg ml–1
kanamycin. Eight colonies were picked and grown in 5 ml of SOB medium at 37°C overnight for
DNA preparation using QIAprep spin columns. Purified DNA was digested by restriction
enzymes (5 µl DNA digested with 0.2 µl of restriction enzyme in 25 µl reaction, incubated at
37°C for 2 hrs) and was separated on a 1% agarose gel to identify clones with the successfully
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captured genomic fragment of the PhLP1 gene into the pStartK plasmid. pStartK-PhLP1 was
designated for clones with expected restriction patterns. Several clones of pStartK-PhLP1 were
sequenced to confirm junction regions of the captured sequences.
Insertion of the 1st LoxP site into the Targeting Vector
Two primers were designed to insert a LoxP site at 10 bp upstream of the transcription
initiation site of the PhLP1 gene (exon 2) and concomitantly introduce an AflII site for Southern
blot screening and an AscI restriction enzyme site for subsequent cloning. The upstream oligo
sequence was CATGTCTTCCTTGCTCAAGCTAGCAAAAAATCCTTGATACATTTTTC
TTTataacttcgtatagcatacattatacgaagttatcttaagggcgcgccagcattacacgtcttgagcgattgt; and the
downstream oligo sequence was GTAATTTCTCCCCCAGTAACTTATCATCCAGGGTT
GTCATGGTGCCTGGAggcgcgcccacttaacggctgacatgggaatta. The uppercase sequences shared
50-bp homologous sequences with the genomic DNA of PhLP1 intron 1 for Red-recombination.
Sequences in lowercase are for introducing the LoxP site, restriction sites, and amplification of
the chloramphenicol resistance gene (cat) in the plasmid pKD3. PCR was performed using these
primers to amplify the chloramphenicol resistance gene (5 x 25- µl reactions: pKD3, 50 ng; 10x
buffer, 12.5 µl; 25 mM MgCl2, 10 µl; primers, 2.5 µl each at 10 mM; 10 mM dNTP, 2.5 µl; Pfx
Taq, 1.25 µl; H2O is added to a total volume of 125 µl. PCR conditions: 94°C 2 min; 30 cycles
of 94°C 30 s, 59°C 30 s and 68°C 60 s; 68°C 7 min). PCR products were combined and purified
through a QIAprep spin column and eluted with 100 µl H2O. The eluted DNA was digested with
2 µl (20 U) of DpnI for 2 hrs at 37°C. The reaction was re-purified on a QIAgen column and
eluted with 40 µl H2O. The purified PCR product (5 µl, 500 ng) was electroporated along with
pStartK-PhLP1 (5 µl, 500 ng) into 50 µl of Red-competent DH5α/pKD46 cells. The
electroporated cells were rescued in 1 ml of SOC medium and incubated at 37°C for 1 hr. Cells
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were centrifuged briefly at 14,000 rpm in a microfuge for 10 s at 23oC. The supernatant was
discarded, and the pellet was resuspended in approximately 100 µl of the remaining media. Cells
were plated on LB-agar plates with 30 mg ml–1 chloramphenicol and incubated at 37°C
overnight. Several colonies were picked and grown in 5 ml of SOB medium at 37°C overnight
for DNA preparation. DNA were purified and digested to identify correct clones. Clones with
correct restriction patterns were sequenced at the junction regions to confirm successful
homologous recombination. The resulting plasmid was designated pStartK-PhLP1-LoxP-AflII.
Five µg of pStartK-PhLP1-LoxP-AflII plasmid was cut in a 50 µl reaction with 1 µl (10 U) of the
AscI restriction enzyme and incubated at 37°C for 2 hrs. The reaction mix was loaded and
separated on a 1% agarose gel for DNA purification using a QIAgen column and was eluted with
48 µl H2O. A standard ligation reaction was set up to perform self-ligation of the above puriﬁed
DNA plasmid as follows: 5 µl (500 ng) of purified DNA plasmid, 2 µl of T4 DNA ligase buffer
and 1 µl of T4 DNA ligase in a total volume of 20 µl for ligation reaction at 23oC for 2 hrs.
Chemically competent DH5α cells were transformed with 20 µl of the above ligation reaction
mixture by heat shock at 42°C for 1 min. One mL of SOC medium was added for rescue and
incubated at 37°C for 1 h. Cells were centrifuged briefly at 14,000 rpm in a microfuge for 10s at
23oC. The supernatant was discarded, and the pellet was resuspended in the remaining liquid of
100 µl. Cells were plated on LB-agar plates with 50 µg ml–1 kanamycin. Several colonies were
picked for culture and DNA isolation. Restriction digestion and sequencing were used to confirm
successful ligation. Clones with correct sequences and restriction patterns were designated
pStark-PhLP1-LoxP1-AflII.
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Insertion of the 2nd LoxP site and Neo positive selection cassette into the Targeting Vector
Two primers were designed to insert the second LoxP site downstream of the exon 3 of
PhLP1 gene and concomitantly introduce an AflII site for Southern blot screening and an MfeI
restriction enzyme site for subsequent cloning at this position. The upstream oligo sequence was
GATCACTTTGACTGGGGAATGATTTTAGGTCATAAAACCTAGACAAAAGCcaattgagcatt
acacgtcttgagcgattgt, and the downstream oligo sequence was CTTGAGACTCTCCCGCCTAGC
TGATGTGACTGGGTCTTTTAGGTGATACAataacttcgtataatgtatgctatacgaagttatcttaagcaattgcac
ttaacggctgacatgggaattag. The uppercase sequences shared 50-bp homology sequences with
genomic DNA of PhLP1 intron 3 for red-recombination. Sequences in lowercase are for
introducing the second LoxP site, addition of restriction sites, and amplification of the
chloramphenicol resistance gene in the plasmid pKD3. PCR was performed using these primers
to amplify the chloramphenicol resistance gene (5 x 25- µl reactions: pKD3, 50 ng; 10x buffer,
12.5 µl; 25 mM MgCl2, 10 µl; primers, 2.5 µl each at 10 mM; 10 mM dNTP, 2.5 µl; Pfx Taq,
1.25 µl; H2O is added to a total volume of 125 µl. PCR conditions: 94°C 2 min; 30 cycles of
94°C 30 s, 59°C 30 s and 68°C 60 s; 68°C 7 min). PCR products were combined and purified
through a QIAprep spin column, and the column was eluted with 100 µl H2O. The eluted DNA
was digested with 2 µl (20 U) of DpnI for 2 hrs at 37°C. The reaction was re-purified on a
QIAgen column and eluted with 48 µl H2O. The purified PCR product (5 µl , 500 ng) was
electroporated with pStartK-PhLP1-LoxP-AflII (5 µl, 500 ng) into 50 µl of Red-competent
DH5α/pKD46 cells. The electroporated cells were rescued in 1 ml of SOC medium and
incubated at 37°C for 1 hr. Cells were centrifuged briefly at 14,000 rpm in a microfuge for 10 s
at 23oC. The supernatant was discarded, and the pellet was resuspended in approximately 100 µl
of the remaining media. Cells were plated on LB-agar plates with 30 mg ml–1 chloramphenicol
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and incubated at 37°C overnight. Several colonies were picked and grown in 5 ml of SOB
medium at 37°C overnight for DNA preparation. DNA were purified and digested to identify
correct clones. Clones with correct restriction patterns were sequenced at the junction regions to
confirm successful homologous recombination. The resulting plasmid was designated pStartKPhLP1-LoxP2-AflII.
Two primers were designed to amplify a PCR product that contained the neomycin resistant
gene with two flanking FRT sites. This PCR product was used to ligate with the MfeI-digested
pStark-PhLP1-LoxP-AflII plasmid to insert the NeoR gene in the intron 3 of PhLP1. The
upstream oligo sequence was ATGCATCAATTGGAAGTTCCTATTCTCTAGAAAGTATAG
GAACTTCaggtctgaagaggagtttacgtccag, and the downstream oligo sequence was TAGTCACAA
TTGATTATGTACCTGACTGATGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCgaag
ggttccgcaagctctagtcgag. Sequences in uppercase were for introducing the MfeI site to the PCR
product. Sequences in lowercase were for annealing to the PL451 plasmid and amplification of
the neomycin resistance gene (Neo) and the FRT sequences in the plasmid PL451. PCR was
performed using these primers to amplify the chloramphenicol resistance gene (5 x 25- µl
reactions: PL451, 50 ng; 10x buffer, 12.5 µl; 25 mM MgCl2, 10 µl; primers, 2.5 µl each at 10
mM; 10 mM dNTP, 2.5 µl; Pfx Taq, 1.25 µl; H2O is added to a total volume of 125 µl. PCR
conditions: 94°C 2 min; 30 cycles of 94°C 30 s, 59°C 30 s and 68°C 60 s; 68°C 7 min). PCR
products were combined and purified through a QIAprep spin column, which was eluted with
100 µl H2O. The eluted DNA was digested with 2 µl (20 U) of DpnI for 2 hrs at 37°C. The
reaction was re-purified on a QIAgen column and was eluted with 48 µl H2O.
Five µg of pStartK-PhLP1-LoxP2-AflII plasmid was cut in a 50 µl reaction with 1 µl (10 U)
of MfeI restriction enzyme and incubated at 37°C for 2 hrs. The reaction mix was purified using
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a QIAgen column and eluted with 48 µl H2O. The eluted DNA was dephosphorylated by CIAP
enzyme at 37°C for 30 min and re-purified with QIAgen spin column. A standard ligation
reaction was set up to insert a pre-cut MfeI-FRT-Neo-FRT-MfeI cassette into the MfeI-digested
pStartK-PhLP1-LoxP2-AflII plasmid as follows: 12 µl (~500 ng) of pStartK-PhLP1-LoxP2-AflII
recipient DNA, 5 µl (200 ng) of pre-cut MfeI-FRT-Neo-FRT-MfeI cassette, 2 µl of T4 DNA
ligase buffer and 1 µl of T4 DNA ligase in a total volume of 20 µl for ligation reaction at 23oC
for 2 hrs. Chemically competent DH5α cells were transformed with 20 µl of the above ligation
reaction mixture by heat shock at 42°C for 1 min. One mL of SOC medium was added for
rescue and incubated at 37°C for 1 h. Cells were centrifuged briefly at 14,000 rpm in a microfuge
for 10s at 23oC. The supernatant was discarded, and the pellet was resuspended in the remaining
liquid of 100 µl. Cells were plated on LB-agar plates with 50 mg ml–1 kanamycin. Several
colonies were picked for culture and DNA isolation. Restriction digestion and sequencing were
used to confirm successful ligation. Clones with correct sequences and restriction patterns were
designated pStark-PhLP1-LoxP2-Neo plasmid.
Gateway recombination: adding the negative selection tk cassette
HSV-TK genes were introduced into the targeting vector using Gateway recombination
reaction. The reaction mixture was set up as follows: LR reaction buffer (5x), 1 µl; pStartKPhLP1-LoxP2-Neo, 2 µl; pWS-TK2 linearized with SalI, 1 µl; LR clonase enzyme mix, 1 µl,
incubated at 25°C for 1 hr, 0.5 µl of proteinase K was added to the solution and the solution mix
was incubated for 10 min at 37°C. Chemically competent DH5α cells were transformed with 2
µl of the above reaction mixture by heat shock at 42°C for 1 min. Cells were spread on LB-agar
plates with 100 µg ml–1 ampicillin. The plates were incubated at 30–32°C for 20 to 30 hrs.
Several colonies were picked and grown in 5 ml of SOB medium at 30–32°C for 20 hrs for DNA
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isolation. Correct clones were confirmed by restriction digestion analysis and sequencing.
Correct clones were designated pStartK-PhLPl-LoxP-TK2 (Fig. 3-1 A).
Preparation of DNA for electroporation of ES cells
pStartK-PhLPl-LoxP-TK2 targeting vectors were linearized for electroporation of ES cells.
Approximately 100–150 µg of clean DNA were prepared by digesting 200 µg of targeting vector
DNA with NotI restriction enzyme at 1–2 U per µg DNA in a total volume of 500 µl reaction for
~ 4 h. About 50 ng of digested DNA along with 50 ng of uncut targeting vector and ladder were
run on a 0.8% agarose gel in Tris-acetate-EDTA (TAE) buffer at 100 V for 1 hr to determine the
completeness of the digestion. To purify the 500 µl DNA digest, 1 volume of phenol and 1
volume of chloroform were added, and the tube was hand-shaken vigorously for 1 min. The tube
was centrifuged at 20,000g for 3–5 min at 23oC in a bench-top centrifuge. The supernatant was
transferred into a new tube, and an equal volume of chloroform was added. The tube was handshake vigorously and was centrifuged again at 20,000g for 3-5 min at 23oC. The supernatant was
transferred into a new Eppendorf tube. Approximately 1.6-2 volumes of 100% ethanol were
added. The tube was mixed by gentle inversion to form web-like DNA. The tube was centrifuged
at 3,000g for 2 min, and the supernatant was discarded. The DNA pellet was rinsed with 0.5 ml
of 70% ethanol by shaking. Then the tube was centrifuged at 3,000g for 2 min. The supernatant
was again discarded. The tube was centrifuged briefly at 3,000g for 10 s, and the residual liquid
was removed by pipetting. The linearized DNA pellet was required to be fully dissolved by
gentle pipetting up and down in 100 µl of Tris-EDTA (TE) buffer (pH 7.5, ﬁltered). The
linearized DNA was stored at 4°C until use or at -20°C for long-term storage.
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Gene targeting in mouse ES cells
Two reactions of G4-derived ES cell lines were prepared for electroporation at 250V with or
without 30 µg of the NotI-linearized pStark-PhLP1-LoxP2-TK2 targeting vector. The
electroporation cuvettes were kept on ice immediately after electroporation for 20 minutes. A
negative control with the same amount of G4 ES cells was treated with the electroporation
procedure without the addition of targeting vector DNA. The electroporated mixture were then
plated onto two separate 10-cm dishes with mitomycinC-treated (mitoC-treated) NeoR
(Neomycin resistant) mouse embryonic fibroblasts (MEFs) and grown in ES media (15% Fetal
bovine Serum (FBS), 100 µM MEM Non Essential amino acids, 100 µM β-Mercaptoethanol, 2
mM L-Glutamine, 50 µg/mL Pen/Strep, LIF 10E3) for 24 hours. After the incubation, the media
was replaced with ES media containing 300 µg/mL of G418 and 2 µM FIAU. The media was
replaced with fresh media about every 2-3 days. Within approximately 7-9 days, all colonies
missing the neomycin gene had cleared off and the Neomycin-positive colonies were still viable
in the presence of the selective media. Non-differentiated well-shaped colonies were picked with
a 200-µl pipette and transferred into a 48-well plate containing approximately 100 µl
trypsin/EDTA in each well. After a set of colonies had been picked, the plate was incubated at
37°C for 10 min. Approximately equal volume of ES media (with G418 and FIAU) was added to
each well to inactivate the trypsin. The ES cells were triturated in each well with a multi-channel
pipetman and were transferred to a 48-well plate of mitoC-treated NeoR MEFs. Additional 400
µl of media were added to each well after the transfer. The media was changed upon visible
detection of depleted nutrients. When the ES cells became confluent (from several days to 2
weeks at the most) and populated most of the area in the well, the ES cells were replica-plated
for storage. For replica plating of these ES cells, the media from each well was aspirated and
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washed with 1X PBS twice. Then, 100 µl of trypsin/EDTA was added and incubated at 37°C for
10 minutes. After incubation, 100 µl of ES media was added to each well, and the ES cells were
triturated ~20 times. Approximately 100 µl of ES cells were transferred into two separate 48well plates with mitoC-treated MEFs for master plate storage and DNA preparation.
Approximately 400 µl of additional media were added to each well. When the ES cells had
populated most of the area of the master plate, the wells were washed with 1X PBS and added
with 100 µl trypsin / EDTA and incubated at 37°C for 10 minutes. After incubation, 100 µl of ES
media was added and triturated. Approximately 200 µl of 2X freezing media (ES medium with
30% FBS and 20% DMSO) was added to each well and mixed. The entire mixture was
transferred into a cryo-storage tube and placed into a freezing box to store at -80°C. For the DNA
plates, the media was aspirated and washed with 1X PBS once when the ES cells had populated
most of the area of the wells. The ES cells were lysed with 300 µl of DNA lysis buffer and
transferred to a 1.7-mL Eppendorf tube. Approximately 5 µl of proteinase K was added to each
tube and incubated at 37°C overnight. Extraction procedures of genomic DNA from these ES
cells were described in the following section.
Preparation of genomic DNA from ES cells for Southern blot or PCR
To prepare DNA from ES cells for Southern blot analysis or PCR, ES cells were lysed in 1.7ml Eppendorf tubes in ~500 µl of ES cell lysis buffer. About 5 µl of proteinase K (from 20 mg
ml–1 stock) was added to a ﬁnal concentration 0.2 mg ml–1 and incubated at 37°C for 4 hrs
without shaking. About 25 µl of additional proteinase K (from 20 mg ml–1 stock) was added and
incubated at 55°C overnight. An equal volume of phenol:chloroform mix was added to each
tube. The tubes were shaken vigorously for 2 min and centrifuged at 20,000g for 5 min at RT.
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The supernatant was transferred into a new Eppendorf tube, and ~1 ml 100% isopropanol was
added along with 1 µl of glycoblue and 1/10 volume 3 M sodium acetate solution. The DNA was
spun down at 20,000g for 15 min at 23oC and washed with 0.5 of 70% ethanol once. DNA was
again spun down at 20,000g for 5 min and was dissolved in 50 µl TE buffer (pH 7.5) by
incubating at 55°C for 30 min.
Southern blotting screening of stem cell
The screening of ES cells was carried out by Southern blotting. Radioactive-labeled probes
were prepared using the Ready-To-Go DNA labeling beads (Amersham) following the
manufacturer’s instructions. Probes were purified with G50 columns (ProbeQuant G-50 Micro
Columns from Amersham). Genomic DNA from ES cells were digested with the following set
up: 5–10 µg of genomic DNA in ~15 µl were digested with AflII (10–20 U) in a 25 µl reactions
in the presence of 4 mM spermidine for 12–20 hrs at 37°C. The digested DNA were separated by
adding 10 µl of 6X loading dye, heated at 65°C for 10 min and loaded onto a 0.7% agarose gel in
1 x TAE buffer. An appropriate amount of 1 kb DNA ladder was also included in a control lane.
The samples were run at 20-50 V for about 4-5 hrs. The gel was then photographed under UV
light and exposed under extended UV irradiation for a total of 5 mins. The DNA was transferred
into Hybond N+ nylon membrane (Amersham) by downward capillary transfer using a protocol
described previously [165]. The gel was denatured in 3 M NaCl, 0.4 M NaOH for 1 hr, and DNA
was blotted onto a Hybond N+ membrane in 3 M NaCl, 8 mM NaOH for approximately 4 hrs.
The nylon membrane was neutralized in 0.2 M sodium phosphate, pH 6.5 and UV-crosslinked
with a UV Stratalinker 1800 for 3 mins. The membrane was placed in a sealed plastic bag for
prehybridization in an oven set at 42°C with 7.5 mL of hybridization solution (Millipore). After
approximately 1.5 to 2 hrs, the radioactive probe was added to the plastic bag, and the bag was
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re-sealed. The probed was boiled for 10 mins and snapped cooled on ice prior to use. The
hybridization reaction was incubated at 42°C for 18-40 hrs. After hybridization, the membrane
was washed twice in 2X SSC, 0.1% SDS at 23oC for 15 min and once in 0.2 X SSC, 0.1% SDS
at 42°C for 10–15 min. The membrane was placed into a phosphor imaging cassette at 23oC for
approximately 18-40 hrs and visualized using a Phosphor-Imager system.
Karyotyping and microinjection
Karyotyping and microinjection were performed in the University of Utah Transgenic Mice
Core facility. Successfully generated chimeric embryos were implanted into the uteri of
surrogate mothers. The chimeric offspring were further inbred to produce homozygous mice that
carried the PhLP1-loxP mutation. The neo gene that was needed for positive selection was
removed by crossing the PhLP1-loxP mice with FLP transgenic mice. The progeny were
screened for the neo gene deletion by PCR for identifying complete neo excision strains.
The mice containing the fully processed PhLP1-loxP gene were then bred with the
Rhodopsin-Cre (iCre75) mice and further inbred to produce homozygous PhLP1-loxP+/+
iCre75+/- mice, designated PhLP1F/FCre+ mice. The reduction in PhLP1 expression in rod cells of
these mice was confirmed by immunocytochemistry and immunoblotting of protein extracts.
PhLP1 expression levels were compared to littermates lacking the PhLP1-LoxP mutation.
Genotyping of PhLP1 knockout mice
Genotyping of knockout mice was carried out by Southern blotting for germline transmission
confirmation, and PCR was used for routine genotyping of mice from subsequent breeding.
Approximately 0.5 cm tail tissue was put in a 1.7-mL Eppendorf tube containing 480 µl of tail
lysis buffer for the isolation of genomic DNA. About 25 µl of proteinase K (from 20 mg ml–1
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stock) was added and incubated at 55°C overnight. An equal volume of phenol:chloroform mix
was added to each tube. The tubes were shaken vigorously for 2 min and centrifuged at 20,000g
for 5 min at RT. The supernatant was transferred into a new Eppendorf tube, and ~1 ml 100%
isopropanol was added along with 1 µl of glycoblue and 1/10 volume of 3 M sodium acetate
solution. DNA was spun down at 20,000g for 15 min at 23oC and washed with 0.5 of 70%
ethanol once. DNA was again spun down at 20,000g for 5 min and was dissolved in 200 µl TE
(pH 7.5) by incubating at 55°C for 30 min. For quick preparation of DNA for PCR genotyping, a
small mouse ear clip tissue was boiled in 75 ul Hotshot lysis solution [164] for 1 hr and
neutralized with 75 µl of 40 mM Tris-Cl. Approximately 3 µl of the mixture was used for PCR
genotyping in a 25 µl reaction.
Several primers were designed to genotype these mice. P3: GATCACTTTGACTGGGGAA
TGATTTTAGGT; P4: GAGGTGGTAAGCAGGTGTACTGGCTGGTTT; P_Neo: GGCGGCA
TCAGAGCAGCCGATTGTCTGTTGTGCCCAGTCATAGCCGAATA. Multiplex PCR
reactions for genotyping were set up at follows: (25-µl reactions: DNA, 3 µl; 10x amplification
buffer, 5 µl; PCR enhance, 5 µl; 25 mM MgCl2, 0.5 µl; primers, 1.25 µl each at 10 mM; 10 mM
dNTP, 0.75 µl; Pfx Taq, 0.2 µl; H2O was added to a total volume of 25 µl. PCR conditions: 94°C
5 min; 30 cycles of 94°C 30 s, 50°C 30 s and 68°C 60 s; 68°C 7 min). PCR products were loaded
and separated on 1% agarose gels. Presence of a band size of 844 bp indicated the presence of
the neomycin gene in the intron 3 of the PhLP1 gene. After crossing with Flp-mice, the
disappearance of this band indicated the removal of neomycin from the genome. Subsequently,
genotypes of PhLP1F/F (704 bp), PhLP1F/+ (704 bp, 600 bp) and PhLP1+/+ (600 bp) were
determined according to the presence of corresponding band sizes (Figure 3-2 E). Genotyping for
determination of the presence of Flp and Cre genes in these mice were performed according to
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the Jackson Lab web protocol (http://jaxmice.jax.org; strain: 129S4/SvJaeSor-Gt(ROSA)
26Sortm1(FLP1)Dym/J) and [166], respectively.
Assessment of photoresponse by ERG
Prior to ERG recordings, age-matched mice were dark-adapted overnight and anesthetized by
intraperitoneal injection using 60 mg ketamine and 10 mg xylazine per kilogram of body weight.
Pupils were dilated by adding a drop of 1% tropicamide for 10-15 min to the eyes. A recording
electrode was placed on the cornea with a reference electrode inserted subcutaneous above the
skull. ERG responses were measured using a UTAS E-3000 (LKC Technologies, Inc.,
Gaithersburg, MD) apparatus according to [167]. Scotopic ERG recordings of both PhLP1F/FCre+
and controls were performed with different intensities of light flashes between -40 to 20 dB. The
recovery time of the scotopic ERG between each flash varied from 10 sec to 60 sec (depending
on the flash intensities) at low intensities ≤ 0.39 log cdS m-2. For flash intensities > 0.39 log
cdSm-2, the recovery intervals between two flashes was 2-5 min. Photopic ERGs recordings were
performed under a background light of 1.48 log cdS m-2 and the stimulating flash intensities
varied from -0.61 to 2.89 log cdS m-2. The recovery time of photopic ERG between each flash
varied from 10 sec to 2 min depending on the flash intensities. The amplitudes of the a-wave and
b-wave at different light intensities were compared between the PhLP1F/FCre+ and controls.
Immunohistochemistry and assessment of photoreceptor degeneration
The expression levels of PhLP1 and transducin subunits in rod photoreceptors in these mice
were tested by immunocytochemistry as described previously [167-169]. Briefly, superior
hemisphere of eyes from age-matched PhLP1F/FCre+ and control mice were cautery-marked for
orientation. These eyes were enucleated under ambient illumination without adaptation and were
immersion-fixed for 2 hr using freshly prepared 4% paraformaldehyde in 0.1 M phosphate buffer
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(pH 7.4) and cryo-protected overnight in 30% sucrose in 0.1 M phosphate buffer (pH 7.4). The
cornea and lens were then removed, and the eyecups were embedded in optimal cutting
temperature (OCT) compound and cryosectioning was performed. Cryosections of 12 µm were
cut through the optic nerve head along the vertical meridian and were placed on superfrost
microscope slides. For immunohistochemistry, sections were rinsed in 0.1 M PBT, and blocked
for 1 hr using 10% normal goat serum, 0.1% Triton X-100 in 0.1 M phosphate buffer (pH 7.4).
Primary antibodies to PhLP1 (1:250 dilution), Gαt1 (1:50, Santa Cruz Biotechnology), Gβ1
(1:200, Santa Cruz Biotechnology) and Gγ1 (1:50, Santa Cruz Biotechnology) were applied to
each group of four sections in a humidified chamber overnight at 4°C. After rinsing in three 10min PBT washes, rhodamine- or fluorescein isothiocyanate-conjugated secondary antibodies
(Jackson ImmunoResearch Laboratories, West Grove, PA; catalog no. 711-295-152 and 715096-150) at a 1:200 dilution were applied for 2 hrs at room temperature. The sections were
viewed using a Zeiss LSM 510 inverted Laser Scan confocal microscope with a 60x, 1.3
numerical aperture oil objective lens and an optical slit setting of <0.9 µm. Images were taken
consistently inferior to the optic nerve of each section.
Cryosections with intact morphology were used for further analysis to determine
photoreceptor degeneration as described previously [170] . These sections were labeled with 100
ng/ml 4'6 diamidino-2-phenylindole dihydrochloride (DAPI) nuclear stain for 30 minutes in the
dark and were then mounted and coverslipped. Digital images were then acquired and were used
to measure the outer nuclear layer thickness in the superior central retina approximately 100 µm
from the edge of the optic nerve head.
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Determination of Gt subunit and PhLP1 expression
Whole retina extracts were prepared from eyes of age-matched PhLP1F/FCre+ mice and
controls under ambient illumination [171]. These retinas were harvested and placed in ice-cold
RIPA buffer (1x PBS with 2% NP-40 and 6 µl/mL Sigma Protease inhibitor cocktail). The
retinas were then passed through an 18G needle 20 times and a 25G needle 10 times to release
the proteins. Extracts were centrifuged at 13,800 rpm for 10 min at 4°C to remove cellular
debris. Protein concentrations were determined by BCA protein assay, and extracts with equal
amounts of protein were loaded and separated by electrophoresis on 10% polyacrylamide gels
and transferred onto nitrocellulose membranes using an iBlot transfer apparatus (Invitrogen).
After blocking with Licor Blocking buffer for 1 hr, membranes were immunoblotted for each of
the transducin subunits as well as other visual proteins as indicated. The amounts of each protein
in the immunoblots were quantified using a LICOR Odyssey near-infrared imaging system and
compared to controls.
Results
Generation of rod-specific PhLP1 conditional knockout mice
The design of the targeting vector for inserting the loxP sequences into the PhLP1 gene is
shown in Fig. 3-1. The circular DNA plasmid contains the PhLP1 gene flanked by two
homologous arms of approximately 2.9 kb and 5kb in length with loxP sequences in introns 1
and 3 (Figure 3-1 A-C). At these positions, the loxP sequences did not cause a frame shift in the
amino acid sequence of PhLP1. Thus, the endogenous PhLP1 gene was replaced with the PhLP1LoxP construct without affecting the native PhLP1 function until the Cre recombinase was
expressed to disrupt the expression of PhLP1. This targeting vector also contained neomycin

77

Figure 3-1. Design of pStartK-PhLP1-LoxP-TK2 targeting vector.
A) Vector map for the conditional deletion of PhLP in mouse rod photoreceptor cells is depicted here. The
main components of the targeting vector for developing the conditional knockout mouse are shown. B) The
number of bands, cleavage ends, sequence coordinates, and length (bp) for the AflII-SpeI restriction digestion
of the final targeting vector are shown. This table was generated using NEB cutter v2.0
(http://tools.neb.com/NEBcutter2/index.php) C) Validation of the final targeting vector by AflII and SpeI
restriction digestion. Lane 1: 1kb DNA ladder Lane 2: AflII-SpeI digested final targeting vector. Band sizes
are indicated.

resistance (neo) and thymidine kinase (TK) genes for the positive and negative selection (Figure
3-1 A).
Electroporation of ES cells, positive/negative selection
The targeting vector was linearized with the NotI restriction enzyme and purified with
phenol/ chloroform/isopropanol precipitation. The linearized targeting vector was electroporated
into G4 hybrid ES cells lines to substitute for the endogenous pdcl gene by homologous
recombination. G418 and FIAU were used to carry out positive and negative selection on the
electroporated ES cells, respectively. The correctly targeted ES cell clones were screened by
Southern blotting. Fig. 3-2 A-D shows different genotypes of the ES cell lines indicated by the
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Figure 3-2. Southern blot and genotyping analysis of ES cells and chimeric mice.
A-C) The maps of wild type (A), incomplete incorporation B) and complete incorporation C) of LoxP sites in the
pdcl gene along with the restriction site of AflII and EcoRV are shown. The annealing site of probe 1 and 2 are
indicated in each map. For 5' end (upstream) probing in the Southern analysis, ES cell DNA were digested with
AflII restriction enzyme and were hybridized with probe 1. The predicted band sizes for wild type, incomplete
incoporation and complete incorporation were 7.2 kb, 8.3 kb, and 4 kb, respectively. For 3' end (downstream)
probing, ES cell DNA were digested with EcoRV restriction enzyme and were hybridized with probe 2. The
predicted bands size for wild type and targeted (both incomplete incoporation and complete incorporation) are
9.4 kb and 11.3 kb, respectively. D) Southern blot analysis of DNA from selected G4 mice ES cell lines after
positive and negative selection is shown. Lanes 1-3 show the results from 5' end probing using AflII digestion
and probe 1 hybridization. Lane 4 shows the results from 3' end probing using EcoRV digestion and probe 2
hybridization. Lane 1 and 2 show the patterns for the genotype of wild type and an incorrectly targeted allele.
Lanes 3 and 4 show the patterns for the genotype of correctly targeted allele. E) Genotyping of PhLP1 CKO
mice by PCR. Two primers (P3, P4) were used in the PCR to amplify the 600 bp product from the PhLP1 gene
and/or the 704 bp product from the PhLP1-LoxP allele containing residual sequences from the removal of the
neomycin resistance cassette. Genomic DNA was extracted from mouse ear clip tissues as described in text. F)
Southern blot analysis of DNA obtained from 1) tail tissue of a B6 mouse 2) ES cells that were used for
blastocyst implantation, 3) tail tissue of a blastocyst implantation-generated PhLP1-loxP chimeric mouse.
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map and their corresponding Southern blotting results. Among 121 ES cell clones that were
screened, 16 were targeted at the pdcl allele with 2 having correct incorporation of both loxP
sites at the right location of the pdcl locus. Therefore, the efficiency for selecting correctly
recombined ES cells was approximately 2%.
Karyotyping, Generation of Chimeric mice and Genotyping
Karyotyping revealed that a clone with the desired mutation termed G2B1 contained ES cells
with 84% having 40 chromosomes, 12% having 39 chromosomes, and 4% having 41
chromosomes. Blastocyte microinjections were performed on these ES cells, and they
successfully generated 15 chimeric mice that carried the desired PhLP1-LoxP construct.
Genotyping by PCR and Southern blot were performed on these mice and confirmed successful
insertion of the PhLP1-LoxP in place of the pdc1 gene (Figure 3-2 E-F). Breeding with Flp and
iCre75 mice have produced PhLP1 conditional knockout mice in retinal rod photoreceptor cells.
Only the mice with PhLP1F/FCre+, PhLP1F/+Cre+, and PhLP1+/+Cre+ genotypes were used in
subsequent experiments for characterization.
Assessment of photoresponse by ERG
Electroretinography (ERG) was used to assess the effects of PhLP1 deletion in the retinal
function. ERG technology is based on the recording of complex field potentials initiated in the
retina by light responses detected by placing an electrode on the cornea [172]. The initial
negative deflection, designated as the a-wave, reflects the light-dependent current suppression in
the rod/cone outer segments [173], and the subsequent positive deflection, designated as the bwave, measures the depolarization from the bipolar cells functioning downstream of the
photoreceptor cells in the retinal phototransduction process [174].
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Figure 3-3. Scotopic and photopic ERG analysis of 33- to 37-d-old mice.
A, B). Scotopic ERG recordings were obtained from dark-adapted PhLP1F/FCre+, PhLP1F/+Cre+, and
PhLP1+/+Cre+ mice under increasing intensities of flash stimuli. C, D) Photopic ERG recordings were obtained
from light-adapted mice under increasing intensities of flash stimuli. Traces are shown in log scale and measured
in cdSm2.

ERGs of 5 week old PhLP1F/FCre+ mice and controls were recorded under various conditions.
Under a low intensity flash, a prominent b-wave was detected in dark-adapted (scotopic) WT
mice. However, no detectable b-wave was found in the scotopic ERG of PhLP1F/FCre+ mice
under the same conditions, indicating a significant defect in the rods and/or in the rod bipolar
cells. Under higher light intensities, a characteristic a-wave was detected in dark-adapted control
mice. In contrast, the a-wave was largely absent in dark-adapted PhLP1F/FCre+ mice (Figure 3-3
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A and B), suggesting that the rod cells of these PhLP1F/FCre+ mice were unresponsive to light.
Although these mice showed b-wave signals under high intensity flashes, these photoresponses
were closely similar to the murine cone b-wave [173, 175] suggesting that under bright lights,
only cone bipolar cells were activated (Figure 3-3 A and B). The maximal amplitude of the
scotopic b-wave, which was dominated by the responses from rod bipolar cells, was also reduced
by approximately 50 – 60% in dark-adapted PhLP1F/FCre+ mice, which is consistent with the
observed a-wave reduction. To test whether these PhLP1F/FCre+ mice retain normal cone
functions, they were exposed to a background light that suppresses over 95% of the rod
circulating current [173]. Under this rod-saturating background, PhLP1F/FCre+ mice and controls
showed very similar photopic ERG responses (Figure 3-3 C and D), further indicating that the
recorded responses from these PhLP1F/FCre+ mice originated from cone-driven bipolar cells.
Immunohistochemistry and assessment of photoreceptor degeneration
Results of immunohistochemistry showed that PhLP1 was successfully knockout in the rod
cells (Figure 3-4 A-H). The signals from PhLP1 antibodies were mostly absent in the outer and
inner segment of the photoreceptor cells since 97% of these cells are rods in mice. PhLP1 was
also absent in the outer nuclear layer. Detectable amount of PhLP1 was found in the outer
plexiform layer, which is mainly composed of biopolar cells and horizontal cells and the synaptic
nerves of the photoreceptors (Figure 3-4 A-B). This observation was expected because the
knockout only targeted the rod cells. The signals from the Gαt1, Gβ1 and Gγ1 subunits were all
significantly diminished in the PhLP1F/FCre+ mice (Figure 3-4 C-H). Since Gβ1 is expressed to
some extent in all cell types of the retina, it was seen in the cells of the inner retina, but its
expression is drastically reduced in the photoreceptor cell layer. In addition, both Gαt1 and Gγ1,
which are only expressed in photoreceptors, showed similarly decreased expression levels. This
82

Figure 3-4. Immunohistochemical analysis of PhLP1 and transducin
subunits.
A-H) Expression of PhLP1 and G protein transducin αβγ subunits are shown
as indicated. Proteins were detected with a rhodamine-conjugated seconday
antibody (fluorescent red). Scale bar = 20 µm. The outer segment (OS), inner
segment (IS), outer nuclear layer (ONL), outer plexiform layer (OPL) and
inner nuclear layer (INL) are labeled in panel B.
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marked decrease in Gt subunits explains the lack of the a-wave in the ERG experiments because
in the absence of Gt, phototransduction cannot occur [171].
Morphological analysis of 5 week old PhLP1F/FCre+ retinas (Fig. 3-4) showed normal
maturation of photoreceptor cells and retinal development. The outer nuclear layer that consists
of photoreceptor nuclei can serve as a gauge for the number of rods present in the photoreceptor
cells, and at 5 weeks of age, the outer-nuclear-layer thickness of PhLP1F/FCre+ mice was similar
to controls. The thickness of the outer nuclear layers measured in the 5-week old PhLP1F/FCre+
mice and controls were approximately 100 µm indicating that the loss of PhLP1 in rods did not
severely hinder the health of the photoreceptor cells, and there are negligible changes in the
thickness of the outer nuclear layer. This result indicated that PhLP1 is not essential for the
viability of the rod outer segments.
Determination of PhLP1 and Gt subunit expression
Whole retina extracts from PhLP1F/FCre+ mice and controls were used to analyze the effects
of PhLP1 knockout on protein content. The protein expression of PhLP1 and all three Gt subunits
were dramatically reduced (Figure 3-5 A and B; 3-6 A and B). PhLP1 expression in the whole
retina was reduced to 25% of wild-type. The remaining PhLP1 comes from retinal cell types
other than rods which are known to express PhLP1. Gαt1 and Gγ1, which are only expressed in
rods, were reduced to 32% and 16% of wild-type, respectively. Gβ1, which like PhLP1 is found
in other retinal cell types [176], was reduced to 35% of wild-type. This finding demonstrates that
Gt subunit expression in rods is dependent on PhLP1 in vivo. Interestingly, retinal expression of
other Gβ and Gγ subunits is also reduced in the PhLP1F/FCre+ mice. Gβ4 expression was reduced
by 95% and Gγ3 expression was reduced by 80%. In contrast, Gβ3 expression is not reduced in
the PhLP1F/FCre+ mice, which is consistent with the observation that Gβ3 is expressed in murine
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Figure 3-5. Immunoblots of whole retina extracts from 33- to 37-d-old mice.
A) Immunoblots of retina lysates probed with antibodies raised against PhLP1, RGS9 and major
G protein subunits expressed in retina. B) immunoblots of other important photoreceptor
proteins. Retina lysates obtained from PhLP1F/FCre+, PhLP1F/+Cre+, and PhLP1+/+Cre+ mice are
indicated.

cones and bipolar cells, but not in rods [177, 178]. Interestingly, the expression of the rod
specific Gβ5L-RGS9-1 complex which is the Gαt GTPase that sets the rate of recovery of the
photoresponse, is dramatically reduced in the PhLP1F/FCre+ mice, while the Gβ5S isoform, which
is not expressed in rods, is not reduced. These findings demonstrate that PhLP1 plays an
important role in the expression of Gβγ and Gβ5L-RGS9-1 dimers in rod photoreceptors.
Most other visual proteins were not affected by the knockout of PhLP1 in rods indicating that
the down regulation of PhLP1 was specifically affecting G protein dimer assembly (Figure 3-5
B; 3-6 B). One exception was Pdc, which is a known Gβγ binding partner in rods and has been
shown to be reduced when Gβγ levels are reduced [174, 176]. The fact that rhodopsin and other
proteins that localize to the rod outer segment are not reduced in the absence of PhLP1 indicates
that the rods are not degenerating and that the outer segments do not have serious defects. This
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Figure 3-6. Retinal protein expression levels in 33- to 37-d-old mice.
Levels of protein expression in PhLP1F/FCre+ and PhLP1F/+Cre+ retina extracts were compared to PhLP1+/+Cre+
for normalization. A) Percentages of protein expression levels of PhLP1, RGS9 and major G protein subunits
expressed in retina are shown in graph corresponding to the immunoblots that were shown in Figure 3-5 A. B)
Protein expression levels of other important photoreceptor proteins expressed in retina are presented here
corresponding to the immunoblots that were shown in Figure 3-5 B.

observation is consistent with the normal morphology of retina under light microscope
observations (Figure 3-4) and shows that the rod specific PhLP1 depletion is not causing a global
disruption of rod function, at least at 5 weeks of age, as was seen with the transgenic overexpression of the PhLP1 ∆1-83 variant [161]. This evidence for normal rod morphology
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indicates that the loss of G protein subunit expression is a direct effect of the absence of PhLP1
and is not an indirect effect of photoreceptor degeneration or malformation of the rod outer
segments.
Discussion
An essential role of PhLP1 as a co-chaperone with CCT in Gβγ dimer assembly has emerged
from a significant body of evidence accumulated from genetic deletion studies in single-celled
organisms [110, 179], structural studies of the PhLP1-CCT complex [105] and biochemical
studies in cell culture [57, 73, 111, 112, 114, 122]. However, this proposed role of PhLP1 has
not been examined in a mammalian system in vivo. As a result, we used mouse gene targeting
strategies to assess the physiological function of PhLP1 in vivo. We reasoned that a whole
animal deletion strategy would be less informative because disruption of the Gβ1 gene was
embryonically lethal [162] and if PhLP1 was essential for Gβγ assembly, its deletion in the
whole animal would be lethal as well. Therefore, we chose a conditional gene targeting method
to specifically delete PhLP1 from mouse retinal rod cells. We expected the rod-specific PhLP1
conditional knockout mouse to be an ideal system to analyze the effects of PhLP1 on Gβγ
assembly in vivo because both Gβγ subunits and PhLP1 are abundantly expressed in the
photoreceptor cells [139, 180] and the effects of PhLP1 deletion can render readily observable
changes in phototransduction.
Lack of severe photoreceptor degeneration upon PhLP1 deletion
A major concern in making this knockout mouse was that loss of PhLP1 would cause the
rods to degenerate. Like other neurons, photoreceptors are susceptible to degeneration from
perturbation of their protein chaperone systems. This was the case with the rhodopsin promoter87

driven transgenic over-expression of the PhLP1 ∆1-83 dominant negative variant in rods.
Malformation of outer segments and rapid degeneration of the photoreceptors occurred [161].
Fortunately, the conditional PhLP1 knockout mouse did not display this same severe
degeneration phenotype. The immunohistochemistry experiments showed that the photoreceptor
layer thickness was not decreased at 5 weeks when the ERG and protein expression analysis was
performed (Fig. 3-4). Moreover, there was no decrease in expression of rhodopsin or other nonG protein outer segment proteins at this age (Fig. 3-5, 3-6), indicating that the outer segments
were normal. The most likely reason for the lack of severe degeneration in the conditional
PhLP1 knockout compared to the PhLP1 ∆1-83 transgenic is that the over-expressed PhLP1
dominant negative interferes with other CCT functions by blocking the binding of important
CCT substrates like actin and tubulin, whereas PhLP1 deletion only interferes with the cochaperone functions of PhLP1. Therefore, we can conclude that the effects of PhLP1 deletion on
G protein subunit expression and phototransduction were a direct result of loss of PhLP1 and not
an indirect result of outer segment malformation or photoreceptor degeneration.
Effects of PhLP deletion on the photoresponse
The complete loss of the scotopic (dark-adapted) a-wave upon PhLP1 deletion was a
surprise. This total lack of responsiveness has only been observed in the Gαt knockout [171].
There are two separate Gγ1 knockout mouse models and both showed reduced scotopic a-waves,
but not a complete loss of the rod light response [174, 176]. In the Gγ1 knockouts, Gαt and Gβ1
expression was reduced by a similar amount to what we observed in the PhLP1 conditional
knockout. Thus, there was residual Gαt, and it was proposed that this Gαt was able to interact
with rhodopsin and initiate phototransduction in the absence of Gβγ, albeit at a much reduced
rate [174, 176]. This conclusion is brought into question by the total loss of rod light sensitivity
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in the PhLP1 knockout, in which 30% of the normal Gαt complement still remains. A major
difference between the Gγ1 knockouts and the PhLP1 knockout is that expression of other Gβ
and Gγ subunits found in rods, such as Gβ4 and Gγ3 are also reduced in the PhLP1 knockout
(Fig. 3-5 and 3-6), whereas in the Gγ1 knockout they are not reduced [176]. This observation
suggests that the residual phototransduction observed in the Gγ1 knockout mice resulted from
compensatory coupling of Gαt to rhodopsin by Gβ4γ3 or another Gβγ combination found in the
rod outer segments and not coupling of Gαt by itself to rhodopsin. The contribution of Gβγ to
activation of Gα by receptors has been a question in the G protein signaling field for 30 years.
Our results suggest that Gβγ is absolutely required for activation of Gαt by rhodopsin in vivo.
The modestly reduced b-waves at high scotopic light intensities and the near normal bwaves in photopic (light-adapted) conditions suggest that cone phototransduction is not affected
by PhLP1 deletion in the rods and that coupling to cone bipolar cells is normal. Rod responses
are shut-down under light-adapted conditions, so only the cone responses are seen in the
photopic ERG. This result indicates that there is no loss of cone function and that the PhLP1
knockout was correctly targeted to the rods. Moreover, rod degeneration leads to cone
degeneration as well, so normal cone function supports the idea that the loss of the a-wave is not
the result of rod degeneration but of the loss of properly assembled Gt heterotrimers.
Decreased G protein subunit expression supports the model of Gβγ assembly
The model of Gβγ assembly presented in Chapter 1 proposes that PhLP1 is essential for the
release of Gβ from CCT and its association with Gγ. The reduced expression of Gαt, Gβ1, and
Gγ1 in the PhLP1 knockout rods is fully consistent with this notion and extends the proposed role
of PhLP1 to the in vivo situation. Moreover, the reduced expression of Gβ4 and Gγ3 supports the
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conclusion from cell culture studies [122] that PhLP1 is required for assembly of all Gβγ subunit
combinations. Importantly, the drastic reduction in Gβ5L and RGS9-1 expression in rods upon
PhLP1 deletion shows that Gβ5-RGS dimer formation is more PhLP1 dependent than proposed
from the cell culture studies. In those studies, an 80% siRNA-mediated knockdown of PhLP1
resulted in only a two-fold reduction in the rate of Gβ5-RGS7 assembly [122]. One possible
explanation for this difference is that in the cell culture work Gβ5S and RGS7 were both overexpressed and that the higher concentration of subunits resulted in a decreased dependence on
PhLP1 for assembly. Another possibility is that the Gβ5L-RGS9-1 dimer is more dependent on
PhLP1 than the Gβ5S-RGS7 dimer. Whatever the reason, the drastic reduction in Gβ5L and
RGS9-1 in the PhLP1 knockout demonstrates that PhLP1 is essential for Gβ5-RGS9-1 assembly
in rods in vivo.
Another observation worth noting is the 70% reduction in Pdc expression. A very similar
reduction in Pdc expression was observed in the two Gγ1 knockout models [174, 176]. In
addition, a similar reduction in Gβ1 expression was observed in the Pdc knockout [181]. This
result indicates that Pdc and Gβγ mutually stabilize each other from ubiquitin-mediated
degradation [182], which supports the idea that the role of Pdc in photoreceptors is to chaperone
Gβγ as it shuttles between the outer and inner segment of the photoreceptor under bright light
conditions [76, 181]. The stark differences between the effect of PhLP1 knockout on
phototransduction observed here compared to the lack of effect of the Pdc knockout on
phototransduction observed previously [181, 182] underlines the fact that although PhLP1 shares
a high degree of homology with Pdc and they both bind Gβγ, the fundamental role of PhLP1 is
very different from that of Pdc.
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Conclusion
Decreased expression of G protein subunits and significant impairment of phototransduction
in the rod cells of PhLP1 conditional knockout mouse provides strong in vivo evidence that
PhLP1 is required for Gβγ assembly. In addition, the dramatic decrease in Gβ5Land RGS9-1 in
rods indicates that the Gβ5L-RGS9-1 dimer, whose GTPase activity on Gαt plays such a critical
role in turning off the light response, also requires PhLP1 for its assembly. These results provide
sufficient impetus for studies to identify small molecule inhibitors of the Gβγ and Gβ5-RGS
assembly processes. These molecules could be designed to disrupt the PhLP1-Gβ interaction that
is essential for formation of both of these dimers. If such molecules could be found, they could
prove extremely valuable as therapeutics in treating the myriad of diseases caused by excessive
signaling through G protein pathways. For example, lysophosphatidic acid (LPA) is a major
mitogen that contributes to the transformation phenotype of many cancers [183]. LPA is known
to signal through a G protein-coupled receptor. However, good antagonists of the LPA receptor
are lacking. Inhibition of G protein signaling with therapeutics that block Gβγ assembly would
perform the same function as an LPA receptor antagonist by blocking G protein signaling
downstream of the receptor and could thus block LPA-mediated cancer growth and metastasis.
Importantly, the results of this study show that specific inhibition of PhLP1 function can shut
down all downstream Gβγ signaling without affecting the overall health of the cells that are
being targeted. Therefore, this unique power of PhLP1 can be harnessed for designing
therapeutic means to alleviate the diseases associated with pathological Gβγ signaling. By
showing that PhLP1 is mediating Gβγ assembly in vivo, this study has established an essential
part of an important research effort that has the potential for broad reaching benefits to human
health and well-being.
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